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Abstract 
 
 
THE CHARACTERIZATION AND STRUCTURE OF MECHANOSENSITIVE 
CHANNELS OF SMALL CONDUCTANCE 
 
by 
 
Yan Shuen Poon 
 
Doctor of Philosophy in Chemistry 
 
California Institute of Technology 
 
Professor Douglas C. Rees 
 
 
This thesis describes the investigation of the mechanosensitive channel of small 
conductance (MscS).  The Escherichia coli MscS structure shows a homoheptameric ion 
channel with each monomer consisting of 3 transmembrane (TM) helices leading into the 
cytoplasmic domain.  TM3 from each of the 7 subunits form the pore that opens up into a 
cytoplasmic cage, thought to be a molecular sieve.  In order to further knowledge 
regarding the mechanism behind bacterial mechanosensation, several approaches were 
employed.  Homologs from organisms indigenous to environments with temperatures 
ranging from 30°C to 95°C were cloned, expressed, and characterized.  Chimeras were 
constructed between MscS homologs from 6 hyperthermophilic organisms and E. coli 
MscS, exchanging the transmembrane and cytoplasmic domains.  Each protein is 
engineered with an N-terminal His6 tag and a C-terminal FLAG epitope.  4 homologs 
were found to be cytotoxic while 3 chimeras failed to rescue the osmotic-shock 
sensitivity of an E. coli mutant strain lacking endogenous mechanosensitive ion channel 
activity. 
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Studies revolving around the various homologs and chimeras led to the 
crystallization of the Helicobacter pylori MscS homolog.  H. pylori MscS shares 
approximately 35% in sequence identity and was crystallized in space group P212121 with 
cell dimensions a = 123.0 Å, b = 147.4 Å, c = 179.4 Å.  Diffraction data was collected at 
the Stanford Synchrotron Radiation Laboratory at beamline 12-2 to 4.75 Å resolution.  A 
molecular replacement solution was achieved using the program PHASER with the E. 
coli MscS model (PDB: 2OAU).  The refined structure shows a similar overall topology 
with E. coli MscS demonstrating a homoheptameric channel.  The cytoplasmic domain 
maintains the same structure while TM1 and TM2 display slightly tighter packing with 
the pore.  The structure of the pore suggests that H. pylori and E. coli MscS are 
crystallized in the same state. 
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Chapter 1 
 
Introduction to Mechanosensitive Channels 
 
 
Background 
 
 
Biological sensory mechanisms have been well characterized.  Rhodopsins in the 
eyes allow vision.  Olfactory receptors enable the sense of smell.  Transient receptor 
potential ion channels have been shown to be essential for certain aspects of taste.  The 
least understood area has been the characterization of mechanosensitive channels and 
their roles in hearing and touch.  Studies surrounding mechanosensitive channels have 
been focused primarily on bacterial mechanosensitive channels.  These channels exist in 
bacteria to serve as safety valves that activate when the bacterium swells as a result of a 
sudden immersion in a hypoosmotic environment.  The opening of the channels allows 
for the passage of ions and small molecules to re-establish osmotic equilibrium thereby 
relieving the increase of turgor pressure within the cell. 
 
There are two major types of mechanosensitive activities in bacteria: MscL 
(mechanosensitive channel of large conductance) and MscS (mechanosensitive channel 
of small conductance).  The identification of the genes responsible has lead to the 
structure determination by X-ray crystallography for both (Chang G 1998; Bass RB 
2002).  The atomic resolution structures of MscL and MscS have triggered an influx of 
information that contributes to the understanding of the mechanism of these channels. 
 
This dissertation describes a series of efforts to further our structural and 
functional understanding of bacterial mechanosensitive channels.  A process was 
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designed to express and purify crystallographic quantities of MscS channels from various 
organisms while simultaneously characterizing cytotoxicity and activity in Escherichia 
coli.  Chapter 1 introduces the current state of understanding of MscS both structurally 
and mechanistically.  Chapter 2 covers the progress achieved in further studies with E. 
coli MscS.  Chapter 3 describes the cloning, expression, purification, and characterization 
of 9 MscS homologs and 8 MscS chimeras.  Chapter 4 discusses the crystallization of 
Helicobacter pylori MscS.  Chapter 5 deviates slightly with tools useful for expressing 
eukaryotic membrane proteins in Escherichia coli. 
 
Three-Dimensional Views of MscS and Related channels 
 
 
In 1998, the crystal structure of Mycobacterium tuberculosis MscL was 
determined by X-ray crystallography at 3.5 Å and revealed a homopentameric channel in 
a closed state (Chang G 1998).  Each monomer is composed of two N-terminal 
transmembrane (TM) domains, TM1 and TM2, that lead into a cytoplasmic helix.  Five 
copies come together with TM1 lining the pore.  The closed-state structure constricts at 
its narrowest point at 2 Å.  Electron paramagnetic resonance spectroscopy and site-
directed spin labeling has indicated that the transition to the open state involves massive 
rearrangements of both TM1 and TM2 to support a pore with a diameter of at least 25 Å 
(Perozo E 2002). 
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Fig. 1-1:  Figure created using the program PYMOL.  The crystal structure of M. 
tuberculosis MscL (PDB: 2OAR) 3.5 Å.  Left:  The MscL pentamer viewed 
laterally with each subunit represented in a separate color.  Right: Polypeptide fold 
of a single MscL subunit 
 
 
 
 
Fig. 1-2:  Figure created using the program PYMOL.  Left: The surface 
representation of the MscL pentamer with acidic residues colored red and basic 
residues colored blue.  The orientation is the same as the pentamer in Figure 1-1.  
Right: The MscL pentamer viewed down the five-fold axis from the periplasmic 
side.  The ribbon diagram is in the exact same orientation as the surface 
representation. 
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Several domains of the MscL structure contribute to the mechanism of the 
channel.  The actual N-terminus is not visible in the MscL crystal structure.  Deletion and 
substitution of amino acids in that region was found to dramatically affect channel 
function (Blount P 1996).  Molecular dynamics simulations has suggested that the TM1-
TM2 periplasmic loop serves to resist channel opening (Meyer GR 2006).  The role of the 
cytoplasmic helical bundle is largely unknown.  Similar to MscS, it is thought to perhaps 
function as a filter. 
 
In 2002, the crystal structure of E. coli MscS was determined by X-ray 
crystallography at 3.9 Å and revealed a homoheptameric channel in what was initially 
believed to be an open state (Bass RB 2002).  The structure shows two major domains: a 
transmembrane region containing the pore and a cage-like cytoplasmic domain.  Each 
monomer consists of three transmembrane domains, TM1, TM2, and TM3, which lead 
into the cytoplasmic domain.  TM1 and TM2 together are thought to be the membrane 
stretch sensor and quite potentially also a voltage sensor due to the presence of an 
arginine residues that seemingly locate within the membrane.  This observation was 
likened to the voltage sensor of voltage-gated sodium and potassium channels.  Although 
voltage-modulation of channel gating has not been seen experimentally by a number of 
groups, there has been clear evidence for the voltage dependence of channel inactivation 
(Akitake B 2005).  TM3 from each monomer comes together to form the channel pore.  
The pore is continuous with the cytoplasmic cage, a large chamber approximately 40 Å in 
diameter.  As mentioned before, a paucity of biochemical and electrophysiological data 
surrounding the cytoplasmic domain has lead to the idea of the cytoplasmic domain 
functioning as a molecular sieve. 
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Fig. 1-3:  Figure created using the program PYMOL.  Ribbon diagrams of the E. coli 
MscS crystal structure (PDB: 2OAU) determined at 3.9 Å resolution.  Left:  The MscS 
heptamer viewed laterally with each subunit represented in a separate color.  Right: 
Polypeptide fold of a single MscS subunit 
  
Fig. 1-4:  Figure created using the program PYMOL.  Left: The surface representation 
of the MscS with acidic residues colored red and basic residues colored blue.  The 
orientation is the same as the heptamer in Figure 1-3.  Right: The MscS heptamer 
viewed down the five-fold axis from the periplasmic side.  The ribbon diagram is in the 
exact same orientation as the surface representation. 
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Functional Understanding of the MscS Gating Cycle 
 
 
MscL and MscS differ in most of the basic properties of a mechanosensitive 
channel.  The pressure threshold for MscL is approximately 1.5 times greater than that for 
MscS.  MscL is not selective whereas MscS favors anions over cations.  It has been 
shown that the voltage dependence of MscS lies in inactivation as opposed to activation.  
Voltage alone has never been demonstrated to be sufficient to activate the channel 
(Martinac B 1987).  However, recent studies have observed the dependence of channel 
inactivation on voltage (Akitake B 2005).  The inactivation rate was demonstrated to 
increase exponentially with depolarization. 
 
The gating cycle as studied by electrophysiology is as follows.  The transition 
from a closed to a fully open state (C -> O) is strongly dependent on membrane tension.  
The open state is seemingly stable at high tension and moderate voltage.  However, when 
membrane tension falls below the activation midpoint, the channel inactivates around 20 
seconds (O -> I).  The inactivated state is both nonconductive and relatively long-lived.  
The transition to the inactivated state exponentially increases with a depolarizing voltage 
(negative pipette voltage) and decreases with membrane tension.  The transition from the 
inactive to the closed state requires minutes and is largely voltage independent (I -> C).  
However, at pipette voltages less than -40 mV and greater than +80 mV, MscS enters 
subconducting states (O -> S) that are followed by a transition to inactivation (S -> I) 
(Figure 1-5). 
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Fig. 1-5:  The hypothetical gating cycle for MscS as adapted from Akitake B et al. 
(2007). 
 
 
The crystal structure of E. coli MscS has spawned two types of experiments.  Site-
directed mutagenesis has been employed to identify amino acid residues critical for 
channel function.  Characterizing the mutants was typically carried out by patch-
clamping experiments.  The second type of experiment involves the measurement by 
electron paramagnetic resonance spectroscopy or fluorescence resonance energy transfer 
of specific regions of the channel during the gating cycle.  Further discussion on the 
functional significance of specific residues is found in Chapter 2.  The results of those 
experiments have reiterated the complexity of the MscS channel and reinforce the idea 
that a fuller understanding of the mechanism of MscS necessitates additional structural 
information. 
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Additional Cases of Mechanosensation 
 
 
The mechanism of mechanosensation is very different from the other senses.  
Taste, smell, and vision involve the binding of odorants, hormones, neurotransmitters, 
and other ligands to membrane protein receptors.  However, hearing and touch require 
sensing a change in the physical property of membrane tension.  Mechanosensation is a 
fundamental activity that extends beyond the sense of touch and sound. 
 
Mechanosensative ion channels can be generally described as transducers that 
convert a mechanical force into a chemical or electric signal that an organism can 
process.  There are many examples of such activities.  In our bodies, baroreception is 
necessary for survival.  Amiloride-sensitive epithelial sodium channels (ENaCs) have 
been found in arterial baroreceptor neurons.  The human body senses blood pressure at 
the carotid sinus and the aortic arch.  An increase in arterial pressure causes a membrane 
stretch at these two areas, which then results in a signal that tells the central nervous 
system that the blood pressure is high (Drummond HA 1998). 
 
The transient receptor potential (TRP) channels have recently been demonstrated 
to be suspects for mechanosensitive ion channels.  Experiments performed on C. elegans 
showed that worms lacking a functional OSM-9 protein failed to display avoidance 
behavior when encountering a high osmolality solution.  OSM-9 shares homology with 
the Drosophila melanogaster TRP channel (Colbert HA 1997).  An attempt to isolate 
vertebrate homologs of OSM-9 resulted in the identification of TRPV4 as an 
osmosensitive channel.  However, electrophysiology experiments showed that changes in 
pipette pressure resulted in no activation (Strotmann R 200).  TRPV4 channels are 
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unlikely to function on their own.  On the other hand, the related TRPV2 was consistently 
activated by the application of membrane stretch (Muraki K 2002). 
 
In the plant kingdom, mechanosensitive channels homologous to primarily TM3 
have been isolated and shown to rescue the osmotic-sensitive activity in bacteria lacking 
endogenous mechanosensitive channels (Haswell ES 2006).  These homologs have been 
shown to localize in Arabidopsis thaliana plastids and have been suggested to participate 
in plastid division.  Other homologs in A. thaliana are localized in plant anatomy that are 
known to be sensitive to physical forces, such as root tips (gravitropism) and guard cells 
that open and close to manage the intake of carbon dioxide. 
 
Novel mechanosensitive channels are constantly being identified 
electrophysiologically.  Somatic sensations such as touch, pressure, proprioception, and 
pain are thought to be mediated through mechanosensitive channels.  Low threshold (LT) 
and high threshold (HT) mechanosensitive channels were characterized in patch 
membranes of dorsal root ganglion (DRG) neurons (Cho H 2002).  The LT channels were 
activated by pressures greater than approximately 20 mm Hg, resulting in a slope ???, 
explain further conductance of  51 pS.  HT channels were activated by pressures greater 
than 60 mm Hg and produced a slop conductance of almost 14 pS.  More recently, a third 
channel was characterized in DRG neurons that also was activated at about 20 mm Hg, 
which is similar to the LT channel, but resulted in a conductance of about 23 pS.  This 
new channel was therefore called a low threshold small conductance (LTSC) channel 
(Cho H 2006). 
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 Mechanosensation is a relatively new field that has been growing exponentially 
due to the advent of the path-clamp technique for electrophysiological studies and the 
structure determination of MscL and MscS by X-ray crystallography.  The mechanism of 
stretch sensation and how the physical force is transduced to channel gating is far from 
being understood.  Further knowledge regarding MscS can hopefully be extrapolated to 
an understanding of mechanosensitive channel gating in all systems. 
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Chapter 2 
 
Structural Studies of Escherichia coli MscS 
 
 
Introduction 
 
 
The structure determination of Escherichia coli MscS purified in the detergent 
Fos-choline 14 (FC14) resulted in an heptameric ion channel with a distinct 
transmembrane and cytoplasmic domain.  Each monomer is composed of three 
transmembrane helices.  The native environment of an ion channel involves spanning 
across a lipid bilayer.  However, purification and crystallization of MscS is performed in 
a detergent solubilized state.  One of our goals includes the crystallization of E. coli 
MscS that is purified using a different detergent from FC14 to study the influence of 
detergent on the channel structure. 
 
Only until recently has the role of phospholipids in membrane protein 
crystallization been explored (Zhang H 2003; Long SB 2007) both in terms of the co-
purified lipids and those used as additives to facilitate crystallization.  Evidence in our lab 
with E. coli MscL and the HI1470/71 transporter (Pinkett HW 2007) suggests that the 
overpurification of membrane proteins may lead to delipidation, thereby compromising 
protein stability.  The crystallization of E. coli MscS was also conducted in the presence 
of a brominated lipid as an attempt to investigate the interactions between lipids and the 
channel. 
 
The crystal structure of E. coli MscS enabled biochemical studies site-directed 
mutagenesis.  The complexity of MscS spawned questions regarding the elements of the 
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channel that are directly responsible for function and those that are structurally essential.  
For example, it is has been demonstrated by electrophysiology that the carboxy-terminus 
of MscS is not essential for activity (Schumann U 2004).  In order to further explore the 
structure of E. coli MscS, six truncations were made at various points of the sequence.  
The first (Mut1) is simply TM1 and TM2.  This truncation, not expected to oligomerize, 
was inspired by the structure determination of the voltage sensor from A. pernix KvAP 
(Jiang Y 2003).  The second mutant (Mut2) constructed begins with the pore-lining helix.  
The third mutant (Mut3) is Mut2 with the endogenous N-terminus (residues 1–27) 
attached to the front end.  The fourth mutant (Mut4) is exclusively the cytoplasmic 
domain.  The fifth mutant (Mut5) is exclusively the transmembrane domain.  Lastly, the 
sixth mutant (Mut6) is the entire ion channel without the first 27 residues.  All six 
truncation mutants are characterized in terms of overexpression and function.  Although 
it is not expected for some or all to be functional channels, determining their crystal 
structure may yield a significant amount of information regarding open/closed states and 
channel stability. 
 
This chapter will be a discussion on further studies on E. coli MscS with the 
intention of learning more about the structure, how it might relate to function, and 
influence on the crystal structure by different types of detergent. 
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Background 
 
 
Ion channels are essential for life.  In humans, ion channels are the molecular 
mediators of the action potential, imparting mobility, memory, and the ability to think.  
These activities are necessary for survival.  With respect to bacteria and archaea, ion 
channels are also vital for survival.  Bacterial survival not only involves immune system 
evasion and antimicrobial resistance, but also withstanding chemical (pH) and physical 
(osmotic and temperature) stress.  The maintenance of osmotic balance has been studied 
extensively.  Plant cell turgor is kept relatively constant through transport systems that 
move ions and solutes in and out of the cell (Zonia L 2007).  The study of aquaporins has 
demonstrated how water is conducted through the cell membrane (Jiang J 2006).  When 
bacterial cells encounter a hypo-osmotic environment, water inflow causes the cell to 
swell, leaving the cell envelope in danger of bursting.  However, this is not the case in 
bacteria.  The molecular basis for the response to an osmotic downshock has been 
characterized primarily in Escherichia coli (Sukharev SI 1994; Poolman B 1998; Levina 
N 1999). 
 
There are three distinct mechanosensitive channel activities in Escherichia coli.  
The first is characterized by a large conductance of approximately 3 nS.  The gene, 
MscL, was identified and cloned (Sukharev SI 1994).  A MscL knockout strain of E. coli 
was demonstrated to have no significant growth or survival impairment.  A second 
activity, a product of MscS and KefA (now known as MscK), was later discovered and 
was shown to have a conductance of approximately 1 nS (Levina N 1999).  MscK is a 
member of a large family that can be divided by size: large (> 700 residues) and smaller 
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proteins (~ 250–500 residues).  The smaller subfamily is structurally homologous to the 
C-terminal portion of the large subfamily.  The N-terminus is predicted to be possibly a 
porin.  Escherichia coli, through a BLASTP search (Altschul SF 1997) has three 
members of the large MscK family (MscK, Yjep, and YbiO) and two members of the 
smaller family (YggB and YnaI).  There is very little information concerning the function 
of Yjep, YbiO, and YnaI.  A third activity has been characterized electrophysiologically 
and has been termed MscM with “M” indicating “mini”.  However, genetic information 
responsible for the MscM activity remains unknown (Blount P 1999).  
 
Structure of E. coli MscS in Fos-Choline 14 
 
 
The structure of Escherichia coli MscS reveals a homoheptamer with a 
transmembrane and a cytoplasmic domain (Bass RB 2002).  The transmembrane domain 
of each subunit contains three membrane-spanning helices.  Beginning in the periplasmic 
space, the N-terminus is followed by TM1 (residues 27–60), TM2 (residues 63–90), and 
the pore-lining helix TM3 (residues 93–128).  TM1 and TM2 are organized as 
antiparallel helices that very minimally make contacts with other helices.  The 
permeation pathway formed by the seven TM3 helices is a right-handed helix bundle.  A 
distinct kink at Gly113 causes the helix to run almost parallel to the surface of the inner 
membrane.  This leads into the cytoplasmic domain, which is a large hollow cage.  
Though initially suggested as a molecular prefilter, the cage of MscS is not without 
influence on gating.  Various studies have demonstrated that modifying the cytoplasmic 
domain has an effect on channel function (Koprowski P 2003; Schumann U 2004). 
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Fig. 2-1:  Figure created with the program PYMOL.  Views of the structure of E. coli 
MscS (PDB: 2OAU).  Upper Left: View of pore from the top.  Bottom Left: View of the 
pore from the bottom.  Center: Entire heptamer with transmembrane domain on the top 
and the cytoplasmic cage on the bottom.  Right: Single subunit in the same orientation as 
the center image 
 
 
The cytoplasmic domain is an extensive interweaving of the seven subunits 
creating a cage-like chamber with an interior diameter of approximately 40Å.  The 
chamber is formed by two domains from each subunit, a middle-! and the COOH-
terminal domain.  The middle-! domain from each subunit connects with that of a 
neighboring domain, thereby creating a continuous !-sheet.  The COOH-terminal domain 
has a mixed "/!-structure similar to the ferredoxin fold family in the SCOP database 
(Murzin 1995).  Finally, the C-terminus forms a base that is characterized by a seven-
stranded parallel !-barrel.   
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Mechanism of E. coli MscS 
 
 
Mechanosensitive channels are ubiquitous in all kingdoms.  Those channels in 
bacteria are thought to serve as a survival mechanism against osmotic stress.  The basic 
properties of the mechanosensitive channel of small conductance (MscS) show that the 
diameter of an open state pore is approximately 18 Å and has a conductance of about 1 
nS.  There exists a selectivity with PCl/PK ~ 1.5–3.0 (Corry B 2007).  The !G, which is 
the difference in free energy between the closed and open conformations of the channel 
without an applied membrane tension, is measured to be 7 kT (Martinac 2001).  MscS, 
with an appropriate amount of membrane tension, opens to allow the passage of solutes 
and ions to passage through until the tension dissipates.  The channel is predicted to 
transition through four states: closed, open, desensitized, and inactivated. 
 
There has been considerable debate revolving around the physiological state of 
MscS in the crystal structure (Bass RB 2002).  Initial analysis of the structure, more 
specifically the 7 Å diameter of the pore at the narrowest constriction point, suggested an 
open state.  However, two independent computational studies predicted the MscS 
constriction point to be dehydrated and likely non-conducting (Anishkin A 2004; 
Sotomayor M 2004).  Furthermore, biochemical cross-linking experiments involving E. 
coli MscS suggests that the natural closed state of the channel is more compact in both 
the transmembrane and cytoplasmic domains (Miller S 2003).  Originally, the crystal 
structure of MscS was thought to be in the open state.  However, various groups, based 
on molecular dynamics simulations, believe MscS restrained to the crystal conformation 
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exhibits low conductance (Sotomayor M 2007).  It is commonly believed that the crystal 
structure represents a nonconducting state, and not the natural closed state. 
 
 
 
Fig. 2-2:  The rate of ramping pressure affects the current (Akitake B 2007). 
 
Many interesting electrophysiological features of the E. coli MscS channel have 
been observed.  For example, experiments on MscS show that with slower ramps of 
pressure, MscS ignores the simuli and inactivates.  Unlike MscL and MscK, MscS often 
exhibits a time-dependent inactivation (Levina N 1999; Koprowski P 2003).  Due to the 
presence of several arginines within the lipid bilayer, early studies suggested the 
possibility of voltage modulation in MscS.  However, subsequent studies have shown that 
MscS activation is basically voltage-independent.  Instead, MscS inactivation was shown 
to be tension and voltage dependent (Akitake B 2005).  At negative pipette (depolarizing) 
voltages less than -40 mV and strong positive pipette (hyperpolarizing) voltages greater 
than +80 mV, MscS tends to occupy substates.  Depolarization beyond -40 mV promotes 
transitions to subconducting states followed by transitions to the inactivation state.  
Channel activation has always been observed as an instant conductance increase 
signifying a fast conformational change.  However, inactivation is broken up into 
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multiple subconducting transitions where the rate of inactivation exponentially increases 
with depolarizing voltage and decreases with tension. 
 
Many questions involving the structure and function of Escherichia coli MscS 
still remain.  A major question regarding membrane protein crystal structures surrounds 
the effects of the lipid bilayer on the protein.  The crystal structure of MscS was 
determined in the presence of the detergent fos-choline 14.  Considering the discussion 
regarding what physiological state the structure represents, it is informative to learn about 
the effects, if any, on the conformation of the channel.  Also, to further understand the 
lipid-protein interaction, we also analyze the binding of brominated lipids in the crystal 
structure.  Lastly, we explored the component nature of MscS by creating a series of 
truncations for the purpose of crystallization to visualize the structural effects of various 
domains.  
 
E. coli MscS Truncation Mutant Design 
 
 
Truncation mutant design was based on the original MscS model.  Mut1 produces 
the first two transmembrane domains.  Early studies suggested the possibility of TM1 and 
TM2 of MscS serving as the voltage sensor for a voltage-sensitive mechanosensitive 
channel.  The structural similarity between MscS TM1 and TM2 to the voltage “paddle” 
of KvAP further reinforced this idea.  In the KvAP study, they determined the structure 
of the voltage sensor alone (REF).  Mut2 represents the MscS channel without TM1 and 
TM2.  Mut3 is the same as Mut2, but with the endogenous N-terminus added to TM3 for 
stability purposes.  Visually, there exists a distinct separation of the transmembrane and 
cytoplasmic domains.  Thus, the basis for Mut4 and Mut5 is to investigate the possibility 
 22 
of one domain to exist independently of the other.  Lastly, Mut6 is the full-length channel 
without the disordered N-terminus.  It was of interest to probe whether these mutants, 
except for Mut1 and Mut4, maintain heptameric structure and the osmotic stress response 
activity. 
 
Mut1  
Mut2  
Mut3  
Mut4 
Mut5  
Mut6  
 
Nterm-TM1-TM2 
TM3-CD 
Nterm-TM3-CD 
CD 
Nterm-TM1-TM2-TM3        
TM1-TM2-TM3-CD 
Residues 1–94 
Residues 91–286 
Residues 1–24, 91–286 
Residues 132–286 
Residues 1–143 
Residues 27–286 
 
Nterm = N-terminus  TM = Transmembrane  CD = Cytoplasmic Domain 
 
 
 
 
 
 
Truncation Mut1 Truncation Mut2 
 
Truncation Mut3 
 
 
 
 
 
Truncation Mut4 Truncation Mut5 Truncation Mut6 
 
Fig. 2-3:  Figure created using the program PYMOL.  Graphical representation of the E. 
coli MscS truncation mutants 
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Experimental Procedures 
 
 
Cloning of E. coli MscS Truncation Mutants 
 
 
The production of gene inserts for Mut1, Mut2, Mut4, Mut5, and Mut6 involve a 
one-step polymerase chain reaction (PCR) that utilizes pET28b(+).Flag.MscS as template 
DNA and two oligonucleotides per construct.  PCR introduces PacI restriction sites at the 
ends of each PCR product.  Digestion with the PacI restriction enzyme will enable 
ligation into pET19b.Flag and pET28b(+).Flag.  Plasmids containing each truncation 
mutant will produce the mutant protein with an N-terminal hexahistidine tag and a C-
terminal Flag epitope (DYKDDDK) tag.  The cloning of Mut3 necessitates the deletion 
of solely TM1 and TM2.  This is accomplished by designing oligonucleotides that are 
complementary to both the N-terminus and immediately following, TM3.  PCR of the 
entire pET28b(+).Flag.MscS with the Mut3 oligonucleotides using Pfu Ultra (Strategene, 
TX) loops out the DNA sequence encoding TM1 and TM2.  Digestion of the PCR 
reaction with DpnI removes any template DNA.  Transformation of the reaction will then 
produce colonies harboring plasmids encoding Mut3 protein.  
 
Fig. 2-4: Creation 
of the Mut3 
truncation mutant 
(elimination of 
TM1 and TM2 
while keeping the 
N-terminus) by 
PCR  
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TABLE 2-1 
Primers Designed for Creation of Truncation Mutants 
Mutant Primer A Primer B Summary 
Mut1 5-
CATGTTAATTAACATG
GAAGATTTGAATGTT-3 
5-
GCCTTTAATTAACGCTG
TTTGTACACCCAC-3 
Putative voltage sensor  
Mut2 5-
CATGTTAATTAACGTA
CAAACAGCGTCAGTC-
3 
5-
GCCTTTAATTAACGCA
GCTTTGTCTTCTTT-3 
Channel without the 
putative voltage sensor 
Mut3 5-
GCTAACCAGGCGCTGC
TGCTAAGTGTACAAAC
CGCGTCAGTCATTGCT-
3 
5-
AGCAATGACTGACGCG
GTTTGTACACTTAGCAG
CAGCGCCTGGTTAGC-3 
Mutant 2 with the 
addition of the WT N-
terminus for stability 
Mut4 5-
CATGTTAATTAACGCC
GGAGAATATGTTGAC-
3 
5-
GCCTTTAATTAACGCA
GCTTTGTCTTCTTT-3 
Cytoplasmic domain 
alone 
Mut5 5-
CATGTTAATTAACATG
GAAGATTTGAATGTT-3 
5-
GCCTTTAATTAAACCG
GCTACGCCGCCGAG-3 
Transmembrane domain 
alone 
Mut6 5-
CATGTTAATTAACTAT
GCAGTAAACATCGTG-
3 
5-
GCCTTTAATTAACGCA
GCTTTGTCTTCTTT-3 
MscS without N-terminus 
 
 
Expression of MscS Truncation Mutants 
 
 
Escherichia coli pET28b(+).MscS.Flag and pET28b(+).Mut1-6.Flag are 
transformed into the expression strain, BL21 Gold (DE3) (Stratagene, TX), and spread on 
LB plates containing 50 µL/mL kanamycin sulfate.  A single colony is used to inoculate 
4 mL of TB + 2% glucose in a 15 mL conical culture tube.  Cultures are grown in a 37°C 
incubator while shaking at 200 rpm.  The preculture is then used to inoculate a 60 L 
fermenter containing TB media + 2% glucose and 50 µL/mL kanamycin sulfate.  
Cultures at O.D.600 ~ 3 are then induced with 1 mM IPTG for 1 hour.  Cells are then 
centrifuged and frozen away at -80°C. 
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Growth and Purification of MscS and Truncation Mutants 
 
 
Scale-up of E. coli MscS or a truncation mutant involves a 60 L growth in a 80 L 
BioFlo 5000# fermentor (New Brunswick, NJ).  350 g of cell paste is thawed out in a 
total volume of 600 mL using MscS Buffer A.  Mechanical homogenization can be used 
to facilitate this process.  Next, 1% (w/v) dodecyl-!-D-maltopyranoside (DDM) is added 
and dissolved at 4°C with the help of a stir bar.  Cell lysis is then conducted through three 
cycles of the M-110L Microfluidizer# processor (Microfluidics, MA).  The cell lysate is 
stirred at 4°C for an additional hour to ensure maximal solubilization.  The mixture is 
centrifuged (Beckmann, rotor JA-14, 30,1000 x g, 60 min, 4°C).  The supernatant is 
carefully removed without disturbing the pellet. 
 
All chromatography is conducted on an AKTA Explorer (GE Lifesciences, NJ).  
Due to poor binding, half of the supernatant is applied to a chromatography column 
containing 100 mL Ni-NTA Superflow (Qiagen, CA) that is equilibrated with MscS 
Buffer B1.  After loading, the column is washed with 100% MscS Buffer B1 until the 280 
nm trace approaches baseline.  At that point, the column is washed with 200 mL of 4% 
MscS Buffer B2, 96% MscS Buffer B1.  Eluting the column requires 54% MscS Buffer 
B2, 46% MscS Buffer B1.  200 mL of the eluate, when the chromatograph deflects 
upwards, is collected.  The column is then equilibrated again with 100% MscS Buffer B1 
before loading the second half of the supernatant.  The purification is repeated again as 
before.  Once both halves are complete, the process is repeated by reloading the 
flowthrough in two parts.  This method maximizes the capture of the protein. 
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Approximately 800 mL of eluate is collected.  200 mL of eluate is then applied to 
a column containing 10 mL "-Flag M2-agarose affinity resin (Sigma, MO) that is 
equilibrated with MscS Buffer C1.  It is important again to collect the flowthrough.  After 
loading is complete, 100% MscS Buffer C1 is used to wash the column until the 280 nm 
trace reaches baseline.  100% MscS Buffer C2 is then applied to elute the protein.  The 
protein is eluted as 7 mL fractions into tubes already containing 2 mL of 1.0 M Tris pH 
8.0.  After elution is complete, the column is equilibrated with 100% MscS Buffer C1.  
This purification is repeated three more times with the remainder of the Ni-NTA column 
eluate.  Lastly, the flowthrough is loaded in its entirety to capture any remaining protein. 
 
The Flag eluates are combined and concentrated in a 100 kDa cutoff Amicon$-
Ultra-15 centrifugal filter device (Millipore, MA) to approximately 500 µL.  This is then 
diluted with the addition of 4 mL ice cold dH2O and 500 µL of 10X Thrombin Buffer for 
a final volume of 5 mL.  50 units of thrombin (GE Lifesciences, NJ) are added.  The 
cleavage reaction is rotated slowly at 4°C for 48 hours.  The digested sample is then 
concentrated in a 100 kDa cutoff Amicon$-Ultra-15 centrifugal filter device to 2 mL.  A 
26/60 HiPrep Sephacryl 300 HR column (GE Lifesciences, NJ) is equilibrated with 400 
mL of MscS Buffer D.  The protein is then injected and run at 0.5 mL/min while 
collecting 3 mL fractions between 110 mL and 170 mL.  Visualizing the peak fractions 
by SDS-PAGE is used to identify those fractions for concentrating. 
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TABLE 2-2 
Buffers Used in the Purification of MscS and Truncation Mutants 
MscS Buffer A 20 mM Tris pH 7.5 
20 mM NaCl 
30 mM imidazole pH 
7.5 
2 mM MgCl2 
protease inhibitor tablets 
0.1 mM PMSF 
0.05 mg/mL DNAse 
0.2 mg/mL lysozyme 
MscS Buffer 
B1 
20 mM Tris pH 7.5 
500 mM NaCl 
30 mM imidazole pH 7.5 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
 
MscS Buffer 
B2 
20 mM Tris pH 7.5 
500 mM imidazole pH 
7.5 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
MscS Buffer 
C1 
20 mM Tris pH 7.5 
150 mM NaCl 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
MscS Buffer 
C2 
100 mM Glycine pH 3.5 
150 mM NaCl 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
Thrombin 10X 
Buffer 
200 mM Tris pH 8.4 
1.5 M NaCl 
25 mM CaCl2 
 
MscS Buffer D 20 mM Tris pH 7.5 
150 mM NaCl 
10% Glycerol 
0.01% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
  
 
 
Characterization of Escherichia coli MscS Truncation Mutants 
 
 
Membrane isolations were conducted to assess whether expression of the 
truncation mutants resulted in accumulation in the membrane.  Membrane preparations 
are carried out by thawing out 5 g of cell paste in a total volume of 35 mL using MscS 
Buffer A.  Mechanical homogenization can be used to facilitate this process.  Cell lysis 
was carried out by sonication.  Unlysed cells were separated by centrifugation (Beckman, 
rotor JA-14, 10,000 x g, 45 min, 4°C).  The supernatant is carefully removed.  
Membranes were then collected by ultracentrifugation (Beckman, rotor Ti-45, 150,000 x 
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g, 60 min, 4°C).  Membranes are then resuspended in 5 mL MscS Buffer A and 
solubilized with 1% (w/v) Fos-choline 14, DDM, or LDAO.  The solution is then batch 
loaded with 1 mL of Ni2+-NTA Superflow Resin (Qiagen, CA) that is pre-equilibrated 
with MscS Buffer B1.  The resin is separated by brief centrifugation and washed three 
times with 5 mL MscS Buffer B1 + 0.05% (w/v) Fos-choline 14, DDM, or LDAO.  
Elution is carried out with 5 mL of 46% MscS Buffer B1:54% MscS Buffer B2 + 0.05% 
(w/v) Fos-choline 14, DDM, or LDAO.  Samples are taken from the eluate and run on 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for Western 
immunoblot using the "-Flag antibody as a probe. 
 
Osmotic Shock Analysis of E. coli Truncation Mutants 
 
 
Plasmids (pET19b.Flag constructs) are transformed into the MJF465 strain of E. 
coli.  Single colonies are grown in 4 mL LB in the presence of 100 µg/mL ampicillin at 
37°C to an O.D.600 of approximately 0.400.  Two modified LB (Luria Bertani) media are 
made and sterilized: LB with 830 mM NaCl and LB with 0 mM NaCl.  At an O.D.600 of 
approximately 0.400, 1 mL of the growing culture is combined with 1 mL of LB (830 
mM NaCl) and 2 mM IPTG.  The cultures are induced for 1 hour and optical density of 
the different samples are measured to normalize by cell density.  The osmotic downshock 
of the normalized samples involves diluting cells 1:500 with LB (0 mM NaCl) for 20 
minutes.  The control samples are diluted 1:500 with LB (500 mM NaCl) for 20 minutes.  
The reactions are then diluted 30X with LB(500 mM NaCl) before plating.  The last 
dilution factor may be optimized depending on the surface area of the plate. 
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Crystallization Trials 
 
The crystallization of E. coli MscS purified in DDM was approached de novo 
using 24-well vapor diffusion trials in hanging drop format.  Crystallization was still 
achieved by using PEG 3350 as the precipitant.  However, a huge amount of salts and 
various buffer systems were compatible with crystallization at 4°C.  The crystallization of 
E. coli MscS Mut3 that is purified in DDM was approached in a similar fashion by 
setting up 24-well vapor diffusion trials in sitting drop format with commercial screens.  
Trials were conducted at both 4°C and 20°C. 
 
Results 
 
 
Expression and Characterization of MscS Truncation Mutants 
 
The expression and purification of the MscS truncation mutants was studied 
together.  It is clear from the results in Figure 2-5 that a significant amount of protein 
accumulates in the cell membrane.  The Western immunoblots show the eluates from 
small-scale purifications of isolated membranes containing the truncation mutant of 
interest.  It is surprising to see that Mut4 localizes to the cell membrane as the 
transmembrane domains have been removed.  Purifying the truncation mutants in FC14, 
DDM, and LDAO result in comparable yields. 
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Expression and Purification 
of Truncation Mutants 
1) Mut1 - FC14 
2) Mut1 - DDM 
3) Mut1 - LDAO 
4) Mut2 - FC14 
5) Mut2 - DDM 
6) Mut2 - LDAO 
7) Mut3 - FC14 
8) Mut3 - DDM 
9) Mut3 - LDAO 
10) Mut4 - FC14 
11) Mut4 - DDM 
12) Mut4 - LDAO 
 
 
Expression and Purification 
of Truncation Mutants 
1) Mut5 – FC14 
2) Mut5 – DDM 
3) Mut5 – LDAO 
4) Mut6 – FC14 
5) Mut6 – DDM 
6) Mut6 – LDAO 
 
 
Fig. 2-5:  "-Flag Western immunoblot detailing the expression and purification was the MscS 
truncation mutants.  Small-scale purifications of the truncation mutants from isolated 
membranes was successful for all mutants in FC14, DDM, and LDAO. 
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Osmotic Shock Analysis of MscS Truncation Mutants 
 
 
The osmotic shock analysis of all six truncation mutants shows that they do not 
retain any of the osmotic shock resistance activity.  The surprising result is Mut6, where 
only the first 26 residues are removed.  These residues are largely disordered in the E. 
coli MscS structure.  Mut6, along with Mut2, Mut3, and Mut5, are not only unable to 
confer protection against an osmotic downshock, but are inherently cytotoxic.  In the 
condition where the cells do not experience the downshock, plates revealed little or no 
colonies.  However, removing parts of the protein is still of structural interest.  The 
modification of structural elements could possibly enable the channel to crystallize in a 
new energy minimum, that of a different state in the gating cycle. 
 
 
Osmotic Shock Analysis of 
Truncation Mutants 
1) Mut1  
2) Mut2 
3) Mut3 
4) Mut4 
5) Mut5 
6) Mut6 
7) Empty Plasmid 
8) pET19b.EcoMscS.Flag 
add discussion about 
toxicity of 2,3,5,6 
Fig. 2-6:  Osmotic downshock analysis of the six truncation mutants derived from E. 
coli MscS.  None of the mutants conferred resistance to an osmotic downshock. 
 
 
Crystallization of Escherichia coli MscS Mut3 
 
 
The initial crystallization of E. coli MscS Mut3 purified in DDM involves vapor 
diffusion in a sitting drop setup with 500 uL of mother liquor and a drop ratio of 1 µL of 
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protein to 1 µL of mother liquor.  MscS Mut3 crystals form in 100 mM HEPES pH 7.5 
and 30% PEG 300 at 4°C.  Crystals were characterized as protein by UV fluorescence 
microscopy (Figure 2-7). 
 
  
Fig. 2-7: Crystals of E. coli MscS Mut3 purified in DDM.  Left: Light microscope 
image of crystals.  Right: UV-induced fluorescence image confirming protein crystals 
 
 
 Crystallization of Escherichia coli MscS 
 
The crystallization of E. coli  MscS purified in DDM involves vapor diffusion in a 
hanging drop setup with 500 µL of mother liquor and a drop ratio of 2 µL of protein to 2 
µL of mother liquor.  Bipyramidal MscS crystals form in 100 mM HEPES pH 7.2, 150 
mM sodium formate, 8% glycerol and 16% PEG3350 at 4°C.  Crystals also form in the 
presence of 0.5% CHAPS and 0.5 mg/mL 1-palmitoyl-2-stearoyl(6-7)dibromo-sn-
glycero-3-phosphocholine.  These crystals exhibited a large Br edge fluorescence and 
formed without significant modification of the unit cell. 
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Discussion 
 
 
 Crystallization of E. coli MscS in DDM 
 
 
Crystals of E. coli MscS purified in 
DDM were grown in space group P43212 with 
cell dimensions a = b = 183.5 Å, c = 263.2 Å, " 
= ! = % = 90° and contained one heptameric 
channel per asymmetric unit.  All data were 
collected at -170°C on beamline 12-2 at the 
Stanford Synchrotron Radiation Laboratory (SSRL) with a Mar 325 X-ray protein 
crystallography detector and processed with MOSFLM 
(Leslie 1992). 
 
 Rigid body refinement was conducted on the 
native data using the E. coli MscS 2OAU model and the 
program REFMAC5 (Murshudov GN 1999).  Rigid 
body domains were created for each of the seven 
subunits as detailed in Table 2-4. 
 
Structure of E. coli MscS purified in DDM 
 
 The crystallization of E. coli MscS that was purified in DDM has no significant 
structural differences to that purified in FC14.  As a result of the interactions between the 
detergent micelles and the transmembrane domain, one might expect variations to exist in 
that region.  However, as seen in Figure 2-8, no dramatic changes exist. 
TABLE 2-3 
Summary of Data Collection and 
Refinement Statistics 
 Native 
Wavelength (Å) 
Resolution (Å) 
Unique reflections 
Redundancy 
Completeness 
I/& 
Rmerge 
0.97946 
39 – 4.5 Å 
27308 
5.1 
99.7 (100.0) 
14.8 (3.7) 
0.084 (0.36) 
TABLE 2-4 
Rigid Body Domains for 
Refinement of MscS 
Domain # Residues 
1 27-61 
2 62-89 
3 90-113 
4 114-121 
5 122-127 
6 128-167 
7 168-181 
8 182-268 
9 269-280 
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Fig. 2-8:  Fitting the E. coli MscS (DDM) model and the E. coli MscS (FC14) model 
(PDB: 2OAU) using the program COOT.  Figure created using the program PYMOL.  
Top:  Overall fit  Bottom:  Zoomed in on TM1 and TM2 from subunit F.  In both images, 
the E. coli MscS (DDM) is magenta.  E. coli MscS (FC14) is in yellow 
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Chapter 3 
 
Characterization of MscS Homologs and Chimeras 
 
 
Introduction 
 
 
The study of different states of channels and transporters has exclusively been 
conducted through atomic resolution structures of different proteins.  Crystal structures of 
different ABC transporters, namely BtuCD (Locher KP 2002) and HI1470/1 (Pinkett HW 
2007), have led to an understanding of how ATP catalysis couples to the transport of 
substrates.  Similarly, the mechanism of potassium ion conductance through channels has 
been demonstrated by the closed- and open-state crystal structures of the S. lividans KcsA 
(Doyle DA 1998) and the MthK (Jiang Y 2002) channels, respectively. 
 
One of the methods used to obtain structural information regarding different 
mechanistic states of MscS involves targeting MscS homologs and the creation of E. coli 
MscS chimeras with homologs from hyperthermophilic organisms.  Contrary to making 
strategic point mutations or truncations, exploring homologs is an easier way to search 
sequence space.  Our crystallization methods are typically conducted at a temperature 
range between 4°C and 25°C.  In defining the list of proteins to attempt, optimal growth 
conditions and sequence homology served as the parameters.  Particular emphasis was 
placed on homologs from thermophilic and hyperthermophilic bacteria and archaea.  
Mechanosensitive channels of both large and small conductance can be triggered solely 
by the lateral stretching of the membrane. 
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Membrane fluidity increases with temperature.  A recent fluorescence polarization 
study on the effects of temperature on the cell membranes of various bacterial species 
under a range of 10 °C to 50°C indicates a general trend of increased fluidity with 
increasing temperature for all bacteria (Vincent M 2004).  A crystallographic approach 
involves the study of homologs of the protein of interest from hyperthermophilic 
organisms.  Proteins that typically function at high temperatures are believed to be more 
stable at temperatures used for crystallization.  It was originally suggested that the crystal 
structure of E. coli MscS showed the mechanosensitive channel to be in an open state 
(Bass RB 2002).  At significantly higher temperatures, the heightened fluidity will lead to 
increased fluctuations in lateral tension.  Thus, is important for the associated MscS 
homologs to maintain a closed state.  Homologs from organisms of such variable growth 
environment at ambient temperatures may exist in different states. 
 
This chapter discusses the production and characterization of MscS homologs and 
various chimeras of the homologs with Escherichia coli MscS for the purpose of 
determining the crystal structure of another functional state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41 
Background 
 
 
MscS Homologs 
 
 
The investigation of full-length, wildtype MscS homologs is a proven method to 
search sequence space.  The crystallization of a mechanosensitive channel of large 
conductance was enabled only through trials surrounding a set of MscL homologs.  
Ultimately, structural information was attained from the Mycobacterium tuberculosis 
MscL homolog (Chang G 1998).  Emphasis was placed on homologs from 
hyperthermophilic organisms due to their inherent thermostability.  Many of such 
organisms arise from the third domain of living organisms, Archaea.  Although it is 
poorly understood and studied, a fraction of its thermostability may result from the four 
differences in the cell membrane.  The membrane phospholipids feature an opposite 
glycerol stereochemistry, isoprenoid groups as opposed to fatty acid tails, ether instead of 
ester linkages, and the sometimes present tetraether lipids (Ulrih NP 2007).  However, 
part of the temperature resistance most likely lies within the primary structure of the 
proteins.  With the dramatically different lipid bilayer environment, it is unknown how 
archaeal MscS homologs will behave in E. coli at 37°C.  Such uncertainty resulted in the 
population of the target homolog list with mesophiles, thermophiles, and 
hyperthermophiles (Table 3-1). 
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TABLE 3-1 
Summary Table of MscS Homologs 
 MW per 
monomer (kD) 
Organism Cell Wall Growth Temperature 
1 31.7 Archaeoglobus fulgidus Gram Negative 83°C 
2 30.6 Aeropyrum pernix Gram Negative 90°C 
3 33.3 Chlorobium tepidum Gram Negative 40–50°C 
4 30.9 Escherichia coli Gram Negative 37°C 
5 30.4 Helicobacter pylori Gram Negative 37°C 
6 37.4 Pyrococcus furiosus Gram Negative 100°C 
7 31.3 Thermoplasma acidophilum Gram Negative 55–60°C 
8 31.5 Thermoplasma volcanium Gram Negative 33–67°C 
9 30.4 Thermotoga maritima Gram Negative 80°C 
10 32.7 Thermus thermophilus Gram Negative 65°C 
11 31.0 Vibrio cholerae Gram Negative 37°C 
 
 
A MAFFT alignment of the protein sequences of the 11 MscS homologs shows 
that most of the homology lies in the cytoplasmic domain (Katoh K 2005).  Considerable 
biochemical and electrophysiological studies have been carried out on the E. coli MscS 
channel.  The carboxy-terminus of MscS has been the target of various studies.  The 
deletion of amino acid residues 266–286 was shown to have no effect on membrane 
accumulation and produced a physiologically functional channel.  However, the channel 
did not re-open after full desensitization (Schumann U 2004).  Attention has been placed 
on the pore-lining residues, more specifically, on the glycine residues of transmembrane 
helices 3a and 3b.  One such study replaced Gly104 and Gly108 with alanines and 
Ala106 with larger residues (Edwards MD 2005).  Their electrophysiological studies 
showed that these mutations resulted in a mutant channel that require a higher gating 
pressure.  These experiments resulted in a proposed closed-to-open transition mechanism 
that indicated the importance of having “smooth” interfaces between the pore-lining 
helices.  The “roughness” introduced is reversible where mutating Ala106 to glycine 
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suppresses the defects caused by original mutations at Gly104 and Gly108.  Another 
study examined Gly113 and Gly121 and their roles in the gating cycle of MscS (Akitake 
B 2007).  Electrophysiological studies showed that the mutant G113A is resistant to 
inactivation.  G121A slowed channel closure and inactivation.  As seen in Figure 3-1, 
Gly121 is conserved across all 11 organisms whereas poor conservation exists at the E. 
coli Gly113.  The mutation to alanines introduces higher helical propensity.  The double 
mutant, G113A/G121A, is very toxic and results in a channel that could not inactivate or 
close with release of tension.  A second group examining Gly113 demonstrated that 
whereas most amino acids inhibited transition to the desensitized state, Gly113 to 
methionine had no effect (Edwards MD 2008).  It is interesting to see in the sequence 
alignment that although Gly121 is well conserved, Gly113 is very poorly conserved.  
Interestingly, those amino acids identified in Edwards et al. (2008) to be inhibitive to the 
transition to the desensitized state are present at the Gly113 position in the homologs.   
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Fig. 3-1:  MscS homolog MAFFT alignment (Katoh K 2005) 
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Structural Basis for Chimeras 
 
 
  The structure 
determination of 
Aeropyrum pernix 
KvAP and the Homo 
sapiens !-adrenergic 
receptor demonstrated 
that a secondary 
protein, whether added 
separately like an 
antibody or lysozyme 
integrated as a chimera, 
can be used to mediate 
crystallization contacts  
(Jiang Y 2003; 
Cherezov V 2007; 
Rasmussen SG 2007).  
The crystal structure of 
E. coli MscS 
demonstrates that crystal contacts are made exclusively through the cytoplasmic domain.  
The crystal packing for KvAP, the !-adrenergic receptor, and E. coli MscS is shown in 
Figure 3-2.  Crystallizing MscS homologs, like any membrane protein, was not expected 
to be a trivial process.  However, by creating a chimera between the homolog 
A 
  
B 
  
C 
  
Fig. 3-2: Left: Crystal contacts using the program COOT.  
Right: Structural model using the program PYMOL.  A. A. 
pernix KvAP co-crystallization with FAB fragment (PDB: 
1ORQ)  B. Engineered !-adrenergic receptor with lysozyme 
(PDB: 2RH1)  C. E. coli MscS with all crystal contacts 
localized in the cytoplasmic domain (PDB: 2OAU) 
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transmembrane domain and the E. coli cytoplasmic domain, the cytoplasmic domain can 
serve the same purpose as the fragment antibody-binding domain for KvAP and 
lysozyme for the !-adrenergic receptor.  However, one major assumption is made here 
regarding the oligomeric state of the homologs.  MscS homologs may not necessarily 
share the heptameric state with the E. coli version. 
 
Chimeras between hyperthermophilic MscS homologs with E. coli MscS were 
created in hopes of increasing the chance of success.  Two constructs were made for each 
homolog.  This included the transmembrane domain of the homolog with the cytoplasmic 
domain of E. coli MscS and the transmembrane domain of E. coli MscS with the 
cytoplasmic domain of the homolog.  Protein sequence alignment using MAFFT was 
used to determine where the truncation was made.  We cloned, expressed, purified, and 
characterized these chimeras for the purpose of crystallization trials. 
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Fig. 3-3:  Figure 
created using the 
program PYMOL.  
Summary of the 
chimeras constructed 
between 
transmembrane and 
cytoplasmic domains 
of hyperthermophilic 
MscS proteins and 
cytoplasmic and 
transmembrane 
domains of E. coli 
MscS, respectively.  
Positions were based 
on sequence 
alignments and 
TMHMM. 
 
 
 
Experimental Procedures 
 
 
Modification of Commercial Vectors 
 
 
In order to facilitate the process of inserting genes into various vectors, multiple 
commercial vectors were modified to include a shared restriction site and a DNA 
sequence that encodes for a Flag epitope tag that is used for purification.  The PacI 
restriction enzyme recognizes an 8 base pair site that is fairly rare in DNA sequences.  
Therefore, in order to facilitate the cloning process, pET19b, pET26b(+), and pET28b(+) 
were engineered to include a PacI site along with a C-terminal FLAG epitope.  A linker 
with overhanging bases was designed for each vector.  First, the original pET19b and 
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pET28b(+) were digested with 10 units of NdeI in the presence of 10 units of calf 
intestinal alkaline phosphatase.  The pET26b(+) plasmid was digested with 10 units of 
BamH1 in the presence of 10 units of calf intestinal alkaline phosphatase. 
 
TABLE 3-2 
Primers Designed for Modification of Commercial Vectors 
 Linker A Linker B 
pET19b, 
pET28b(+) 
5-
CATACGTTAATTAACGATTA
TAAGGATGACGACGATAAG
TAATATGGCTAGCAT-3 
5-
GTATCGCAATTAATTGCTA
ATATTCCTACTGCTGCTATT
CATTATACCGATCGTACT-3 
pET26b(+) 5-
GATCCGGATTATAAGGATG
ACGACGATAAGTTAATTAAC
-3 
5-
GCCTAATATTCCTACTGCTG
CTATTCAATTAATTGCTAG-
3 
   
 
The linkers (resuspended at 10 µM) are prepared by first treating each linker 
separately with polynucleotide kinase (NEB, MA) for 1 hour at 37°C in a 20 µL reaction.  
The phosphorylated linker A and linker B are then combined and 40 µL of TE is added to 
stop the phosphorylation reaction.  Finally, the linkers are annealed through a temperature 
gradient: 95°C for 3 minutes, 75°C for 7 minutes, 60°C for 5 minutes, 45°C for 5 
minutes, 37°C for 5 minutes, and 14°C for 5 minutes.  The linkers are then diluted further 
with 270 µL TE for a final concentration of approximately 2 ng/µL.  The linker is then 
ligated into the appropriate digested vector overnight at 16°C with 1 unit of T4 ligase 
(NEB, MA). 
 
Cloning of MscS Homologs 
 
 
Genes for MscS homologs were amplified by PCR from genomic DNA obtained 
from the American Type Culture Collection (ATCC) using two primers both containing 
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PacI restriction sites and sequences complementary to the gene of interest.  The amplified 
PCR product was digested for 2 hours at 37°C with 10 units of PacI restriction enzyme 
(NEB, MA) and gel purified using a gel extraction kit (Qiagen).  The digested insert was 
then ligated overnight into our pET19b.Flag, pET26b(+).Flag, and pET28b(+).Flag 
vectors at 16°C with 1 unit of T4 ligase (NEB, MA). 
 
TABLE 3-3 
Primers Designed for the Amplification of MscS Homologs 
Organism Coding Primer A Non-Coding Primer B 
Aeropyrum pernix 5-
CATGTTAATTAACATGGA
TGGATCATCCTCAGAT 
5-
GCCTTTAATTAAACCCTCC
TTCCCCCCGATTTC 
Archaeoglobus fulgidus 5-
CATGTTAATTAACATGGG
GATTATGATTGACGTG 
5-
GCCTTTAATTAAAGCCTGC
CGTCTCTCTTCCTT 
Chlorobium tepidum 5-
CATGTTAATTAACATGGA
ATCAACATCATTGCGT 
5-
GCCTTTAATTAACCCTGTT
GGGTTCTTCCGTTC 
Escherichia coli 5-
CATGTTAATTAACATGGA
AGATTTGAATGTTGTC 
5-
GCCTTTAATTAACGCAGCT
TTGTCTTCTTTCAC 
Helicobacter pylori 5-
CATGTTAATTAACATGGA
TGAAATTAAAACGCTG 
5-
GCCTTTAATTAATTTAGGA
GAGTCTTGATTTTTAAT 
Pyrococcus furiosus 5-
CATGTTAATTAACATGAA
CATCCCCTGGGAAGGA 
5-
GCCTTTAATTAAATCTTTTT
CAAGCTTCACTCT 
Staphylococcus aureus 5-
CATGTTAATTAACATGGA
TCAAGTTATGAGTATT 
5-
GCCTTTAATTAAAACACCG
TTTTCACTATGATT 
Thermoplasma 
acidophilum 
5-
CATGTTAATTAACATGGA
TCGGAGAAACATTCGG 
5-
GCCTTTAATTAACGTACTG
GATTTTGCCTTCCA 
Thermoplasma 
volcanium 
5-
CATGTTAATTAACATGAA
GCAGAGGGCATTGCGT 
5-
GCCTTTAATTAAGGCTTCC
TTCTTTGCTCTCCA 
Thermotoga maritima 5-
CATGTTAATTAACATGCT
CGCCAAACTGATCCTC 
5-
GCCTTTAATTAAACTCTTA
TTTTCAGAGCCTTC 
Thermus thermophilus 5-
CATGTTAATTAACATGAG
5-
GCCTTTAATTAATGGCGTT
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CCACGCCCTAAGCCTT TCCTTAACCACCCG 
Vibrio cholerae 5-
CATGTTAATTAACATGGC
TGGTGAATCGATTGGT 
5-
GCCTTTAATTAAATTGATT
TTGTTCAGATGCAC 
 
 
 
 
Cloning of MscS Chimeras 
 
 
Creation of the gene encoding a chimeric MscS homolog involves a two-step 
polymerase chain reaction (PCR) that requires four oligonucleotides, A through D.  
Details on the primers used is found in Table 3-5.  Amplification of fragment 1 from gene 
1 involves a PCR reaction using primers A and B.  Amplification of fragment 2 from 
gene 2 involves a PCR reaction using primers C and D.  The overhang of primer B 
contains a DNA sequence that is complementary to gene 2. 
 
The overhang of primer C contains a DNA sequence that is complementary to gene 1.  
The products, fragment 1 and fragment 2, are then combined in a PCR reaction involving 
TABLE 3-4 
Summary Table of MscS Chimeras 
Chimeras MW per 
monomer (kD) 
N-terminal C-terminal 
C1 30.5 Aerpyrum pernix Escherichia coli 
C2 30.9 Escherichia coli Aeropyrum pernix 
C3 30.4 Archaeoglobus fulgidus Escherichia coli 
C4 32.3 Escherichia coli Archaeoglobus fulgidus 
C5 33.6 Thermoplasma acidophilum Escherichia coli 
C6 28.5 Escherichia coli Thermoplasma 
acidophilum 
C7 31.5 Thermoplasma volcanium Escherichia coli 
C8 30.9 Escherichia coli Thermoplasma volcanium 
C9 29.0 Thermoplasma maritima Escherichia coli 
C10 32.3 Escherichia coli Thermoplasma maritima 
C11 31.8 Thermus thermophilus Escherichia coli 
C12 31.7 Escherichia coli Thermus thermophilus 
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primers A and D.  A graphical description of the process is shown in Figure 3-4.  The 
amplified PCR product was digested for 2 hours at 37°C with 10 units of PacI restriction 
enzyme and gel purified using a gel extraction kit.  The digested insert was then ligated 
overnight into our pET19b.Flag, pET26b(+).Flag, and pET28b(+).Flag vectors at 16°C 
with 1 unit of T4 ligase.  The MscS chimeras created are listed in Table 3-4. 
 
 
 
Fig. 3-4. Schematic of chimera cloning strategy.  Two rounds of PCR are required to produce 
gene inserts that are compatible with pET19b.Flag, pET26b(+).Flag, and pET28b(+).Flag. 
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TABLE 3-5 
Primers to Create MscS Chimeras 
Chimera Primer A Primer B Primer C Primer D 
C1 CATGTTAATTA
AC 
ATGGATGGATC
ATCCTCAGAT 
TACGGCGA
GAAAAGCTT
CCGTGCCGG
AGAA 
TTCTCCGGC
ACGGAAGCT
TTTCTCGCCG
TA 
GCCTTTAATTA
A 
CGCAGCTTTGT
CTTCTTTCAC 
C2 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGCTG
GTCATCGGC
GAC 
GTCGCCGAT
GACCAGCGG
GCGGAACAT
GAC 
GCCTTTAATTA
A 
ACCCTCCTTCC
CCCCGATTTC 
C3 CATGTTAATTA
AC 
ATGGGGATTAT
GATTGACGTG 
ATCTCGGAG
AAACCGTTC
CGTGCCGGA
GAA 
TTCTCCGGC
ACGGAACGG
TTTCTCCGA
GAT 
GCCTTTAATTA
A 
CGCAGCTTTGT
CTTCTTTCAC 
C4 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGATA
AAAATTGG
AGAT 
ATCTCCAAT
TTTTATCGG
GCGGAACAT
GAC 
GCCTTTAATTA
A 
AGCCTGCCGT
CTCTCTTCCTT 
C5 CATGTTAATTA
AC 
ATGGATCGGAG
AAACATTCGG 
ACATCCGGC
GGTGCGTTC
CGTGCCGGA
GAA 
TTCTCCGGC
ACGGAACGC
ACCGCCGGA
TGT 
GCCTTTAATTA
A 
CGCAGCTTTGT
CTTCTTTCAC 
C6 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGCTG
AAGCCGGG
CGAT 
ATCGCCCGG
CTTCAGCGG
GCGGAACAT
GAC 
GCCTTTAATTA
A 
CGTACTGGAT
TTTGCCTTCCA 
C7 CATGTTAATTA
AC 
ATGAAGCAGA
GGGCATTGCGT 
GCTCTGATC
ATTGGATTC
CGTGCCGGA
GAA 
TTCTCCGGC
ACGGAATCC
AATGATCAG
AGC 
GCCTTTAATTA
A 
CGCAGCTTTGT
CTTCTTTCAC 
C8 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGATT
GCCCTGCAG
AAT 
ATTCTGCAG
GGCAATCGG
GCGGAACAT
GAC 
GCCTTTAATTA
A 
GGCTTCCTTCT
TTGCTCTCCA 
C9 CATGTTAATTA
AC 
ATGCTCGCCAA
ACTGATCCTC 
CTAGTGTCT
CGGGCTTTC
CGTGCCGGA
GAA 
TTCTCCGGC
ACGGAAAGC
CCGAGACAC
TAG 
GCCTTTAATTA
A 
CGCAGCTTTGT
CTTCTTTCAC 
C10 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGGTC
AAGGAAGG
AGAG 
CTCTCCTTCC
TTGACCGGG
CGGAACATG
AC 
GCCTTTAATTA
A 
ACTCTTATTTT
CAGAGCCTTC 
C11 CATGTTAATTA
AC 
CTCCTGGAA
GACCAGTTC
TTCTCCGGC
ACGGAACTG
GCCTTTAATTA
A 
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ATGAGCCACGC
CCTAAGCCTT 
CGTGCCGGA
GAA 
GTCTTCCAG
GAG 
CGCAGCTTTGT
CTTCTTTCAC 
C12 CATGTTAATTA
AC 
ATGGAAGATTT
GAATGTTGTC 
GTCATGTTC
CGCCCGTAC
GGCGTGGG
GGAC 
GTCCCCCAC
GCCGTACGG
GCGGAACAT
GAC 
GCCTTTAATTA
A 
TGGCGTTTCCT
TAACCACCCG 
 
 
Expression of MscS Homologs and Chimeras  
 
 
The homolog and chimera plasmids are transformed into the expression strain, 
BL21 Gold (DE3) (Stratagene), and spread on LB (Luria Bertani) plates containing the 
appropriate antibiotic—kanamycin for pET26b(+).Flag and pET28b(+).Flag constructs 
and ampicillin for pET19b.Flag constructs.  The pET19b.Flag constructs are transformed 
into the MJF465 (Frag1, 'mscL::Cm, 'yggB, 'kefA::kan), a triple knockout strain of E. 
coli that is kindly provided by I.R. Booth (University of Aberdeen, UK) that is missing 
MscL, MscS, and MscK (Levina N 1999).  A single colony is used to inoculate 4 mL of 
TB + 2% glucose in a 15 mL conical culture tube.  Cultures are grown in a 37°C 
incubator while shaking at 200 rpm.  Cultures at O.D.600 of approximately 1 are then 
induced with 1 mM IPTG (isopropyl-!-D-thiogalactopyranoside) for 1 hour.  100 µL of 
O.D.600 = 1 is pelleted in a microfuge and the supernatant is removed.  The pellet is then 
resuspended in 60 µL of 4X SDS-dye loading buffer.  Samples are then loaded onto a 
SDS-PAGE gel for a Western blot analysis.  The Western blot is probed with an "-Flag 
antibody. 
 
Membrane Isolation of MscS Homologs and Chimeras  
 
 
Membrane isolation is performed in order to characterize whether expression 
results in membrane accumulation as opposed to the production of inclusion bodies.  2L 
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of each pET28b(+).Flag construct was grown and harvested.  15 g of cell paste was 
thawed out in a total volume of 35 mL using MscS Buffer A.  Mechanical 
homogenization can be used to facilitate this process.  Cell lysis was carried out by 
sonication.  Unlysed cells were separated by centrifugation (Beckman, rotor JA-14, 
10,000 x g, 45 min, 4°C).  The supernatant is carefully removed.  Membranes were then 
collected by ultracentrifugation (Beckman, rotor Ti-45, 150,000 x g, 60 min, 4°C).  
Membranes are then resuspended in 5 mL MscS Buffer A. 
 
Growth Studies of MscS Homologs and Chimeras  
 
 
MscS homologs and chimeras in pET19b.Flag plasmids were transformed into the 
MJF465 strain.  The plasmids pCTC.EcoMscS, pET19b.EcoMscS, and the empty 
plasmid pET19b.Flag were also transformed into the MJF465 strain for the growth study.  
This strain is a triple knockout that is missing the genes encoding for MscL, MscS, and 
MscK.  The strain is useful for studying the cellular effects of mutations and/or homologs 
in the context of toxicity and the ability to withstand an osmotic downshock.  Single 
colonies were picked and grown overnight in 4 mL of LB containing 100 µg/mL 
ampicillin at 37°C.  Cultures are then diluted with LB and normalized to an O.D.600 of 
0.100.  150 µL of each was grown in a 96-well Corning plate in quadruplicates.  The 
plate was incubated 37°C and shaken using an Infinite M200 Tecan plate reader that 
makes O.D.600 readings every 10 minutes.  Two of the four samples were induced with a 
final concentration of 1 mM IPTG (isopropyl-!-D-thiogalactopyranoside) at 120 minutes.  
The plate was then read for another 60 minutes.  
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Osmotic Shock Analysis of MscS Homologs and Chimeras  
 
 
Plasmids are transformed into the MJF465 strain of E. coli.  Single colonies are 
grown in 4 mL LB in the presence of 100 µg/mL ampicillin at 37°C to an O.D.600 of 
approximately 0.400.  Two modified LB (Luria Bertani) media are made and sterilized: 
LB with 830 mM NaCl and LB with 0 mM NaCl.  At an O.D.600 of approximately 0.400, 
1 mL of the growing culture is combined with 1 mL of LB (830 mM NaCl) and 2 mM 
IPTG.  Cultures are induced for 1 hour and the optical density of the different samples are 
measuredto normalize by cell density.  The osmotic downshock of the normalized 
samples involves diluting cells 1:500 with LB (0 mM NaCl) for 20 minutes.  The control 
samples are diluted 1:500 with LB (500 mM NaCl) for 20 minutes.  The reactions are 
then diluted 30X with LB(500 mM NaCl) before plating.  The last dilution factor may be 
optimized depending on the surface area of the plate. 
 
Growth and Purification of MscS Homologs and Chimeras  
 
 
Scale-up of a particular homolog or chimera involves a 60 L growth in an 80 L 
BioFlo 5000# fermentor (New Brunswick, NJ).  350 g of cell paste is thawed out in a 
total volume of 600 mL using MscS Buffer A.  Mechanical homogenization can be used 
to facilitate this process.  Next, 1% (w/v) dodecyl-!-D-maltopyranoside (DDM) is added 
and dissolved at 4°C with the help of a stir bar.  Cell lysis is then conducted through three 
cycles of the M-110L Microfluidizer# processor (Microfluidics, MA).  The cell lysate is 
stirred at 4°C for an additional hour to ensure maximal solubilization.  The mixture is 
centrifuged (Beckmann, rotor JA-14, 30,1000 x g, 60 min, 4°C).  The supernatant is 
carefully removed without disturbing the pellet. 
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All chromatography is conducted on an AKTA Explorer (GE Lifesciences, NJ).  
Due to poor binding, half of the supernatant is applied to a chromatography column 
containing 100 mL Ni-NTA Superflow (Qiagen, CA) that is equilibrated with MscS 
Buffer B1.  After loading, the column is washed with 100% MscS Buffer B1 until the 280 
nm trace approaches baseline.  At that point, the column is washed with 200 mL of 4% 
MscS Buffer B2, 96% MscS Buffer B1.  Eluting the column requires 54% MscS Buffer 
B2, 46% MscS Buffer B1.  200 mL of the eluate, when the chromatograph deflects 
upwards, is collected.  The column is then equilibrated again with 100% MscS Buffer B1 
before loading the second half of the supernatant.  The purification is repeated again as 
before.  Once both halves are complete, the process is repeated by reloading the 
flowthrough in two parts.  This method maximizes the capture of the protein. 
 
Approximately 800 mL of eluate is collected.  200 mL of eluate is then applied to 
a column containing 10 mL "-Flag M2-agarose affinity resin (Sigma, MO) that is 
equilibrated with MscS Buffer C1.  It is important again to collect the flowthrough.  After 
loading is complete, 100% MscS Buffer C1 is used to wash the column until the 280 nm 
trace reaches baseline.  100% MscS Buffer C2 is then applied to elute the protein.  The 
protein is eluted as 7 mL fractions into tubes already containing 2 mL of 1.0 M Tris pH 
8.0.  After elution is complete, the column is equilibrated with 100% MscS Buffer C1.  
This purification is repeated three more times with the remainder of the Ni-NTA column 
eluate.  Lastly, the flowthrough is loaded in its entirety to capture any remaining protein. 
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The flag eluates are combined and concentrated in a 100 kDa cutoff Amicon$-
Ultra-15 centrifugal filter device (Millipore, MA) to approximately 500 µL.  This is then 
diluted with the addition of 4 mL ice cold dH2O and 500 µL of 10X Thrombin Buffer for 
a final volume of 5 mL.  50 units of thrombin (GE Lifesciences, NJ) is added.  The 
cleavage reaction is rotated slowly at 4°C for 48 hours.  The digested sample is then 
concentrated in a 100 kDa cutoff Amicon$-Ultra-15 centrifugal filter device to 2 mL.  A 
26/60 HiPrep Sephacryl 300 HR column (GE Lifesciences, NJ) is equilibrated with 400 
mL of MscS Buffer D.  The protein is then injected and run at 0.5 mL/min while 
collecting 3 mL fractions between 110 mL and 170 mL.  Visualizing the peak fractions 
by SDS-PAGE is used to identify those fractions containing the protein of interest. 
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TABLE 3-6 
Buffers Used in the Purification of MscS Homologs and Chimeras 
MscS Buffer A 20 mM Tris pH 7.5 
20 mM NaCl 
30 mM imidazole pH 7.5 
2 mM MgCl2 
protease inhibitor tablets 
0.1 mM PMSF 
0.05 mg/mL DNAse 
0.2 mg/mL lysozyme 
MscS Buffer 
B1 
20 mM Tris pH 7.5 
500 mM NaCl 
30 mM imidazole pH 
7.5 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
 
MscS Buffer 
B2 
20 mM Tris pH 7.5 
500 mM imidazole pH 
7.5 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
MscS Buffer 
C1 
20 mM Tris pH 7.5 
150 mM NaCl 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
MscS Buffer 
C2 
100 mM Glycine pH 3.5 
150 mM NaCl 
0.05% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
Thrombin 10X 
Buffer 
200 mM Tris pH 8.4 
1.5 M NaCl 
25 mM CaCl2 
 
MscS Buffer D 20 mM Tris pH 7.5 
150 mM NaCl 
10% Glycerol 
0.01% DDM 
protease inhibitor tablets 
0.1 mM PMSF 
  
 
 
Crystallization Trials  
 
 
Purified MscS homolog and chimera samples are concentrated with a 100 kDa 
cutoff Amicon$-Ultra-15 centrifugal filter device (Millipore, MA) to a final 
concentration of approximately 10 mg/mL.  Crystallization trials were set up using the 
Mosquito liquid handler (TTP Labtech, MA) using sitting drop trays with 100 µL well 
solution and mixing 0.1 µL protein sample with 0.1 µL well solution.  Trials were set up 
at both 4°C and 20°C.  Commercial screens were utilized. 
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Results 
 
 
Expression of Msc Homologs and Chimeras 
 
 
Expression of the MscS homologs and chimeras by pET26b(+).Flag or 
pET28b(+).Flag in Escherichia coli was determined using whole cell lysates.  The 
plasmid pET26b(+).Flag incorporates an N-terminal secretory signal, pelB, and is 
thought to possibly facilitate expression especially since the N-terminus of E. coli MscS 
is periplasmic.  The presence of the proteins was characterized by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and a subsequent "-Flag 
Western immunoblot (Figure 3-5). 
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Homologs: 
pET28b(+).GOI.Flag  
1) A. pernix 
2) T. acidophilum 
3) T.maritima 
4) A. fulgidus 
5) E. coli 
6) H. pylori 
7) T. volcanium 
8) C. tepidum 
9) P. furiosus 
10) V. cholerae 
 
*GOI = Gene of Interest 
 
Homologs: 
pET28b(+).GOI.Flag versus 
pET26(b+).GOI.Flag  
1) pET26b(+).Aper.Flag 
2) pET28b(+).Aper.Flag 
3) pET26b(+).Taci.Flag 
4) pET28b(+).Taci.Flag 
5) pET26b(+).Tmar.Flag 
6) pET28b(+).Tmar.Flag 
7) pET26b(+).Aful.Flag 
8) pET28b(+).Aful.Flag 
9) pET26b(+).Ecol.Flag 
10) pET28b(+).Ecol.Flag 
11) pET26b(+).Hpyl.Flag 
12) pET28b(+).Hpyl.Flag 
13) pET26b(+).Tvol.Flag 
14) pET28b(+).Tvol.Flag  
Chimeras: 
pET28b(+).GOI.Flag versus 
pET26b(+).GOI.Flag  
1) pET26b(+).C2.Flag 
2) pET28b(+).C2.Flag 
3) pET26b(+).C3.Flag 
4) pET28b(+).C3.Flag 
5) pET26b(+).C4.Flag 
6) pET28b(+).C4.Flag 
7) pET26b(+).C7.Flag 
8) pET28b(+).C7.Flag 
9) pET26b(+).C9.Flag 
10) pET28b(+).C9.Flag 
11) pET26b(+).C10.Flag 
12) pET28b(+).C10.Flag 
13) pET26b(+).C11.Flag 
14) pET28b(+).C11.Flag 
15) pET26b(+).C12.Flag 
16) pET28b(+).C12.Flag 
 
Fig. 3-5:  "-Flag Western immunoblot testing the expression of MscS homologs and 
chimeras.  The middle and bottom blot compare expression levels with respect to the 
different plasmids pET28b(+).Flag and pET26b(+).pelB.Flag.  The pelB signal sequence 
flags the translated polypeptide for secretion across the inner membrane. 
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A common concern regarding the overexpression of membrane proteins in any 
system is whether the protein of interest is accumulating in inclusion bodies or actually 
inserting into the membrane.  A membrane isolation of cells expressing MscS homologs 
and chimeras using pET28b(+).Flag constructs was performed.  An "-Flag Western 
immunoblot was conducted on the membranes.  
 
Homologs: 
pET28b(+).GOI.Flag 
membranes  
1) A. fulgidus 
2) A. pernix 
3) E. coli 
4) H. pylori 
5) P. furiosus 
6) T. acidophilum 
7) T. maritima 
8) T. volcanium 
9) V. cholerae 
 
Chimeras: 
pET28b(+).GOI.Flag 
membranes 
1) Chimera 2 
2) Chimera 3 
3) Chimera 4 
4) Chimera 7 
5) Chimera 9 
6) Chimera 10 
7) Chimera 11 
8) Chimera 12 
 
Fig. 3-6: "-Flag Western immunoblot assessing the protein 
accumulation in the cell membrane 
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Also, growth studies and osmotic shock analysis was performed on the MJF465 
strain expressing MscS homologs and chimeras via the pET19b.Flag vector.  A 
confirmation of actual expression was necessary (Figure 3-7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Homologs: 
pET19b.GOI.Flag 
expression in 
MJF465 
1) A. fulgidus 
2) A. pernix 
3) C. tepidum 
4) E. coli 
5) H. pylori 
6) T. acidophilum 
7) T. maritima 
8) T. volcanium 
9) V. cholerae  
Chimeras: 
pET19b.GOI.Flag 
expression in 
MJF465 
1) Chimera 2 
2) Chimera 3 
3) Chimera 4 
4) Chimera 7 
5) Chimera 9 
6) Chimera 10 
7) Chimera 11 
8) Chimera 12 
 
Fig. 3-7:  The pET19b.Flag constructs are transformed into the 
MJF465 strain for osmotic downshock analysis.  An "-Flag 
Western immunoblot is conducted to confirm expression. 
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Growth Studies of MscS Homologs and Chimeras 
 
 
 MscS homologs and chimeras in pET19b.Flag plasmids are transformed into the 
MJF465 strain of E. coli.  The MJF465 strain lacks endogenous MscL, MscS, and MscK.  
Expressing MscS homologs and chimeras in MJF465 allows for the study of the ability of 
the expressed protein to rescue the osmotic-sensitivity activity that allows for survival.  
However, the expression of heterologous proteins is oftentimes toxic to the host.  
Cytotoxicity can be confused for a negative result in an osmotic shock assay.  Thus, it is 
necessary to perform growth studies in order to gain insight on the distinction between 
cytotoxicity and osmotic shock rescue.  In Figure 3-8, the growth studies revealed 
significant toxicity when expressing homologs from A. fulgidus, A. pernix, C. tepidum, T. 
maritima, V. cholerae, and Chimera 7.  Moderate toxicity was found when expressing 
Chimera 11 whereas mild toxicity accompanied Chimera 2, Chimera 3, and Chimera 4 
expression. 
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Fig. 3-8a: Growth curves of pCTC.EcolMscS and pET19b.EcolMscS in MJF465, 
induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
 
Fig. 3-8b: Growth curves of pET19b.Flag empty plasmid and pET19b.AfulMscS.Flag in 
MJF465, induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
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Fig. 3-8c: Growth curves of pET19b.AperMscS.Flag and pET19b.CtepMscS.Flag in 
MJF465, induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
 
Fig. 3-8d: Growth curves of pET19b.EcolMscS.Flag and pET19b.HpylMscS.Flag in 
MJF465, induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
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Fig. 3-8e: Growth curves of pET19b.TaciMscS.Flag and pET19b.TmarMscS.Flag in 
MJF465, induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
 
Fig. 3-8f: Growth curves of pET19b.TvolMscS.Flag and pET19b.VchoMscS.Flag in 
MJF465, induced and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
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Fig. 3-8g: Growth curves of pET19b.C2.Flag and pET19b.C3.Flag in MJF465, induced 
and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
 
Fig. 3-8h: Growth curves of pET19b.C4.Flag and pET19b.C7.Flag in MJF465, induced 
and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
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Fig. 3-8i: Growth curves of pET19b.C9.Flag and pET19b.C10.Flag in MJF465, induced 
and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
 
Fig. 3-8j. Growth curves of pET19b.C11.Flag and pET19b.C12.Flag in MJF465, induced 
and uninduced.  Red triangle indicates the addition of 1 mM IPTG. 
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Osmotic Downshock Analysis of MscS Homologs and Chimeras 
 
 
The pET19b.Flag constructs containing MscS homologs and chimeras are 
transformed into the MJF465 strain for an osmotic shock analysis to determine whether 
the expression of each of these proteins will impart osmotic downshock resistance.  The 
experiment was performed in triplicates and the mean number of cells is plotted below in 
Figure 3-9.  Results of the osmotic shock analysis show that 5 of the 9 homologs and 4 of 
the 8 chimeras rescued in vivo survival activity when experiencing an osmotic 
downshock while expressed in an E. coli strain devoid of native MscL, MscS, or MscK.  
Homologs from A. fulgidus, A. pernix, C. tepidum, T. maritima and Chimeras 2, 7, and 9 
failed in rescuing the cell from osmotic downshock.  However, the four homologs are 
inherently cytotoxic.  This is demonstrated by the lack of colonies in the “no shock” 
condition. 
 
1 A. fulgidus 
2 A. pernix 
3 C. tepidum 
4 E. coli 
5 H. pylori 
6 T. acidophilum 
7 T. maritima 
8 T. volcanium 
9 V. cholerae 
10 C2 
11 C3 
12 C4 
13 C7 
14 C9 
15 C10 
16 C11 
17 C12 
 
18 Empty Plasmid 
Fig. 3-9:  Osmotic shock analysis demonstrated that expression of five of the 9 
homologs and 4 of the 8 chimeras in strain MJF465 resulted in survival. 
 70 
Discussion 
 
 
Nine homologs and 8 chimeras were comprehensively characterized.  All 
homologs and chimeras were shown to express in Escherichia coli and accumulate in the 
cell membrane.  However, growth studies identified five homologs as toxic: A. fulgidus, 
A. pernix, C tepidum, T. martima, V. cholerae.  The osmotic shock analysis demonstrated 
that A. fulgidus, A. pernix, C. tepidum, and T. martima failed to result in survival.  
However, it is observed that the “no shock” condition also saw massive cell death.  This 
suggests that the failure to rescue osmotic shock resistance activity for these four 
homologs is actually due to their cytotoxicity.  Preliminary characterization of function 
allows for a more strategic approach to crystallizing a MscS homolog.  It is clear from the 
expression testing, growth studies, and osmotic downshock assay that MscS homologs 
from E. coli, H. pylori, T. acidophilum, T. volcanium, and V. cholerae should progress 
forward for crystallization trials. 
 
The same process of elimination can be made for the chimeras.  From the eight 
chimeras that were comprehensively characterized, all were shown to express in the 
membrane of E. coli.  Growth studies show that expression of C7 resulted in significant 
cytotoxicity.  Moderate toxicity accompanied C11 production.  Lastly, mild toxicity was 
observed with C2, C3, and C4 growth.  Osmotic downshock analysis revealed that 
expression of C2, C7, and C9 in the MJF465 strain did not enable the cells to survive.  
Considering both sets of data, it can be concluded that C7 expression kills the cells, 
whereas C11 expression is benign.  However, C11 simply does not rescue osmotic shock 
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resistance activity.  It is clear from these results that the crystallization of C3, C4, C10, 
C11, and C12 should be attempted. 
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Chapter 4 
 
Crystallization and Structural Studies of Helicobacter pylori 
 
 
Introduction 
 
 
The first crystallizations and structure determinations of ion channels were in 
1998 with Streptomyces lividans KcsA and Mycobacterium tuberculosis MscL (Chang G 
1998; Doyle DA 1998).  Following those achievements, the structure of Escherichia coli 
MscS was solved and published in 2002 (Bass RB 2002).  The rate of membrane protein 
structure determination has been orders of magnitude slower than that for soluble 
proteins.  The introduction of robotics has enabled a considerable advantage to the 
crystallization of membrane proteins.  Investigation of MscS homologs and chimeras has 
lead to the crystallization of the Helicobacter pylori MscS homolog.  Initial 
crystallization hits were attained using a high throughput crystallization robot and 
imaging mechanism.  This chapter will cover the crystallization of H. pylori MscS and 
preliminary observations regarding the structure of H. pylori MscS and the subtle 
differences from the crystal structure of E. coli MscS. 
 
Background 
 
 
Sequence Alignment with Escherichia coli MscS 
 
 
There exists no biochemical data on the Helicobacter pylori MscS homolog.  
Identification of the H. pylori MscS homolog was determined by BLASTp and the 
following is the protein sequence alignment with Escherichia coli MscS using MAFFT 
Multiple Sequence Alignment (Katoh K 2005).  Examination of the sequence alignment 
 76 
shows that most of the conserved residues lies in the cytoplasmic domain (is this true?).  
The determination of the crystal structure of E. coli MscS revealed positively charged 
residues in the transmembrane domain of the channel (Bass RB 2002).  This occurrence 
lead to the comparison to the voltage sensing domain of sodium and potassium channels.  
These sites in the E. coli protein sequence include Arg46, Arg54, Arg59, Lys60, Arg74, 
and Arg88.  The alignment shows that Arg46 and Arg74 are replaced in the H. pylori 
sequence by phenylalanines.  Arg54 is conserved in H. pylori as Lys45.  Arg59 and 
Lys60 are seemingly misaligned.  Contrary to the alignment, it appears that those two  
positively charged residues are conserved as Lys 49 and Lys50, respectively. 
 
 
In terms of other charged residues in transmembrane helices 1 and 2, Asp62 is 
conserved.  There exists considerable sequence homology in the remainder of the 
structure.  Notable features of H. pylori MscS that are conserved across other homologs 
include the Gly121 in E. coli MscS, which has been demonstrated to be pivotal for 
channel closure and inactivation (Akitake B 2007).  Structural and electrophysiological 
studies have commented and studied Gly113 in E. coli MscS because it serves as a 
 
Fig. 4-1:  Alignment of Helicobacter pylori and Escherichia coli MscS using MAFFT 
multiple sequence alignment algorithm (Katoh K 2005) 
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structural hinge point in TM3 thereby dividing the helix into TM3a and TM3b (Edwards 
MD 2008).  In Edwards et al. (2008), it was shown that replacing Gly113 in E. coli with 
nonpolar (Ala, Pro) or polar (Asp, Arg, Ser) residues inhibited the transition to the 
desensitized state.  Gly113 is actually very poorly conserved and in other homologs, this 
position is populated with asparagines, serine, and proline.  In H. pylori MscS, the E. coli 
Gly113 is aligned with Asp102.  
 
 Although there exists considerable sequence homology between H. pylori and E. 
coli MscS, structural information of H. pylori MscS would provide a clearer insight on 
the function of mechanosensitive channels by providing another system of study for site-
directed mutagenesis and electrophysiological characterization.   
 
Experimental Procedures 
 
 
Cloning, Expression, and Purification of H. pylori MscS 
 
 
The cloning, expression, and 
purification of H. pylori MscS using 
dodecyl-!-D-maltopyranoside 
(DDM) was discussed in Chapter 3.  
The plasmid used for all experiments 
is pET28b(+).HpylMscS.Flag.  The 
construct encodes for MscS with a C-
terminal Flag epitope and an N-
terminal hexahistine tag that can be 
 
Fig. 4-2:  Purified 
H. pylori MscS 
after Ni2+-NTA 
and Flag antibody 
affinity 
chromatography, 
thrombin cleavage, 
and size exclusion 
chromatography.  
The predominant 
band is the 
monomeric MscS.  
The higher ordered 
species were also 
confirmed as H. 
pylori MscS by 
mass spectrometry. 
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removed by proteolysis with thrombin.  The engineered tags allow for the purification of 
H. pylori MscS by using Ni2+-NTA chromatography and Flag antibody affinity 
chromatography.  The N-terminal hexahistine tag is then cleaved off with thrombin.  
Lastly, size exclusion chromatography step is used to separate out protein aggregates 
from the final protein sample. 
 
Results 
 
 
Crystallization of Helicobacter pylori MscS 
 
 
The Mosquito liquid handler (TTP Labtech, MA) set up sitting drop vapor 
diffusion crystal trays using commercial screens purchased from Hampton Research, CA, 
and Qiagen, CA.  200 nL of the protein was mixed with 200 nL of the well solution.  The 
crystals of H. pylori  MscS appeared within two days, but were too small to notice via the 
automated imaging system. 
 
Image 1: 14 hours 
 
Image 2: 1 day, 15 hours  
 
Image 3: 16 days, 14 hours 
 
   
Fig. 4-3:  High throughput imager results  
 
 
A Protein Review System (Korima, Inc.) was used to characterize the crystals by 
a split fluorescent beam that causes fluorescing protein crystals to stand out against non-
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protein crystals (Figure 4).  Optimization of the crystallization conditions enabled the 
growth of larger crystals. Membrane protein impurities, especially outer membrane 
proteins, at low levels such as 1–5% have been observed to crystallize.  Thus, crystals 
were harvested, sufficiently washed using the mother liquor, and run on SDS-PAGE to 
confirm as being H. pylori MscS.  
 
 Light Microscope UV Fluorescence 
96-well 
screening 
trays 
  
Reproduction 
in 24-well 
trays 
  
Fig. 4-4:  Fluorescence used to confirm crystals as protein 
 
 
Closer examination of the initial screens resulted in a number of crystallization 
leads.  Trays were set up at both 4°C and 20°C covering 500 conditions each.  All crystal 
hits were attained at 20°C (Table 4-1). 
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TABLE 4-1 
Summary of High Throughput Crystallization Hits 
# Condition # Condition # Condition 
1 0.1M NaCl 
30% PEG 400 
0.1M Na3C3H5O(COO)3 pH 
5.5 
2 0.1 NaCl 
30% PEG 400 
0.1M MOPS pH 7.0 
3 0.1M NaCl 
30% PEG 400 
0.1M Tris pH 8.5 
4 0.1M LiSO4 
0.1M NaCl 
30% PEG 400 
0.1M MES pH 6.5 
5 0.1M MgCl2 
0.1M NaCl 
30% PEG 400 
0.1M MES pH 6.5 
6 0.1M MgCl2 
0.1M NaCl 
30% PEG 400 
0.1M HEPES pH 
7.5 
7 0.1M AmSO4 
30% PEG 400 
0.1M HEPES pH 7.5 
8 0.1M NaCl 
30% PEG 400 
0.1M 
Na3C3H5O(COO)3 pH 
5.6 
9 0.1M MgCl2 
0.1M NaCl 
30% PEG 400 
0.1M Tris pH 8.5 
10 0.1M HEPES pH 7.0 
30% Jeffamine ED2001 pH 
7.0 
11 0.2M CaCl2 
20% PEG 3350 
12 0.1M NaCl 
30% PEG 400 
0.1M HEPES pH 
7.5 
Attempted to reproduce 
Attempted and successfully reproduced 
 
 
Optimization of crystallization conditions resulted in larger crystals that diffract to 
resolutions higher than that of the initial hit.  Through the variation of salt and precipitant 
concentration, the pH range, and the usage of additives, crystals were improved in many 
ways.  H. pylori crystals grow up to several hundred microns and diffract to 6-7 Å 
resolution.  Data collection was conducted at the Stanford Synchrotron Radiation 
Laboratory at Beamline 12-2.  With the improvement of the cryoprotectant, the 
diffraction quality improved to 3.8 Å resolution.  Due to radiation damage however, data 
processing has only been extended to 4.75 Å resolution. 
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0.1M Citrate pH 5.0-5.4 
0.2M LiAcetate 
28% PEG 400 
5% glycerol 
500 um length, 300 um 
20°C 
0.1M Citrate pH 5.0 
0.2M LiCl 
28% PEG 400 
5% glycerol 
~250 um 
20°C 
0.1M Citrate pH 5.0 
0.150 M LiAcetate 
28% PEG 400 
5% glyerol 
~100 um 
20°C 
Fig. 4-5:  Optimization of crystallization hits   
 
 
The plasmid pET28b(+).HpMscS.Flag was transformed into B834 (DE3) 
competent cells (Novagen) for the integration of Se-methionine into the protein for de 
novo phasing data.  Single colonies are grown 4 mL LB in the presence of 50 µg/mL 
kanamycin sulfate and used to inoculate 6 L flasks containing 2 L of SeMet Growth 
Media (Appendix B).  Cells are grown at 37°C and induced at O.D.600 with 1 mM IPTG 
for 1 hour.  Cultures are centrifuged and cells are frozen immediately and stored at -80°C.  
Due to the low expression of all MscS proteins, SeMet cell growths are repeated until 350 
g is amassed.  SeMet crystals appeared under the crystallization conditions for the native 
protein. 
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Discussion 
 
 
Crystals of H. pylori MscS were grown 
in space group P212121 with cell dimensions a = 
114.5 Å, b = 143.6 Å, c = 178.7 Å and 
contained one heptameric channel per 
asymmetric unit.  All data were collected at  
-170°C on beamline 12-2 at the Stanford 
Synchrotron Radiation Laboratory (SSRL) with 
a Mar 325 X-ray protein crystallography 
detector and processed with MOSFLM (Leslie 1992). 
 
 Without experimental phases, structural conclusions could only be made through 
molecular replacement with the program PHASER using the E. coli MscS model (McCoy 
AJ 2005).  The density in the three transmembrane helices was not as clear as that for the 
cytoplasmic domain region.  The structure was refined using REFMAC5 (Murshudov GN 
1999).  Using the E. coli model and a H. pylori homology model yielded similar results.  
Various rounds of refinement was applied and compared to validate the model. 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 4-2 
Summary of Data Collection and 
Refinement Statistics 
 Native 
Wavelength (Å) 
Resolution (Å) 
Unique reflections 
Redundancy 
Completeness 
I/& 
Rmerge 
1.000 
39 – 4.75 Å 
laster 
resolution 
shell?? 
14965 
2.8 
97.5 (98.3) 
9.9 (3.0) 
0.077 (0.35) 
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Refinement Method 1 
 
 
Rigid body refinement was performed using 
REFMAC5 with the native data and the PHASER output 
model.  Rigid body domains were created for each of the 
seven subunits as detailed in Table 4-3.  The residue 
range in column 2 of Table 4-3 corresponds to the amino 
acid sequence of E. coli MscS. 
 
Refinement Method 2 
 
 
This process involved building a H. pylori 
homology model and fitting it onto the E. coli MscS heptamer in SwissPdb (Guex N 
1997).  Refinement was also performed in MAIN (Turk 1996) by first doing rigid body 
using each chain as 1 body followed doing a kick map refinement.  Subsequent 
refinement broke each subunit into smaller rigid bodies 
that are based on the homology model (Table 4-4).  The 
residue range in column 2 of Table 4-4 corresponds to 
the amino acid sequence of H. pylori.  Each of the small 
rigid bodies underwent real space refinement with all 
atoms, real space rigid body, and another round of real 
space refinement with all atoms.  Then, each subunit 
containing these small rigid bodies enters a round of real 
TABLE 4-3 
Rigid Body Domains for 
Refinement Method 1 
Domain # Residues 
1 27-61 
2 62-89 
3 90-113 
4 114-121 
5 122-127 
6 128-167 
7 168-181 
8 182-268 
9 269-280 
TABLE 4-4 
Rigid Body Domains for 
Refinement Method 2 
Domain # Residues 
1 18-48 
2 49-54 
3 53-78 
4 78-81 
5 81-99 
6 100-116 
7 116-121 
8 121-155 
9 156-163 
10 165-169 
11 186-202 
12 202-240 
13 240-254 
 84 
space refinement with all atoms.  Lastly, operators are determined for 5 cycles of 
averaging.  It is important to note that model bias, if anything, should impose asymmetry 
between the seven subunits.  Need current R/Rfree values 
 
Structural Observations of H. pylori MscS 
 
 
At 4.75 Å resolution, structural observations are limited to large-scale geometric 
features.  These observations are facilitated by the comparison to the E. coli MscS model.  
Three conclusions can be made regarding the structure of H. pylori MscS.  The first of 
which is that the cytoplasmic domain essentially remains the same.  The second 
conclusion is that the permeation pathway is more symmetric than that for E. coli MscS, 
which is more oval-shaped as one views the structure down the central axis.  It is 
visualized in Figure 4-6. 
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Fig. 4-6:  Figure created using the program PYMOL.  Comparison of the symmetry of 
the pore-lining helices between E. coli MscS (Top) and H. pylori MscS (Bottom) 
 
 
Lastly, overlaying the refinement models from refinement 1 (Figure 4-7) and 
refinement 2 (Figure 4-8) with the E. coli MscS model demonstrates a fairly significant 
difference in the positioning of TM1 and TM2.  Although this occurs at varying degrees, 
TM1 and TM2 essentially tilt outwards, with the N-terminal end of TM1 tilting away 
from the pore and the first cytoplasmic loop maintaining its position or buckling inwards 
slightly.  It remains unclear whether the differences in the structure are specific to H. 
pylori MscS or whether it represents another substate.  The models from refinement 1 and 
refinement 2 are fitted to support the validity of the differences seen between E. coli 
MscS and H. pylori MscS (Figure 4-9). 
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Fig. 4-7:  Fitting H. pyl refinement 1 model (red) and the E. coli MscS (grey) model 
(PDB: 2OAU) using the program COOT.  Figure created using the program PYMOL.  
Top:  Overall fit.  Bottom:  Zoomed in on TM1 and TM2 from subunit F.  In both 
images, the refinement 1 model is the thicker trace.. 
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Fig. 4-8:  Fitting refinement 2 model (green) and E. coli MscS (grey) model (PDB: 
2OAU) using the program COOT.  Figure created using the program PYMOL.  Top:  
Overall fit.  Bottom:  Zoomed in on TM1 and TM2. In both images, the refinement 2 
model is the thicker trace. 
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Fig. 4-9:  Fitting refinement 1 model and refinement 2 model to demonstrate two 
methods arriving at similar results.  Although not exact, the positioning of TM1 and TM2 
between the two models is closer than between the models and E. coli MscS 
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Chapter 5 
 
Production of Eukaryotic Membrane Proteins in Escherichia coli 
 
 
Introduction 
 
 
Membrane proteins are instrumental in the most basic functions in life.  A plant 
must open and close guard cells in order to regulate CO2 entry.  The MscS-like channel 
(MSL4) has been postulated to participate in that mechanism (Haswell ES 2006).  An 
herbivore, using olfactory G-protein coupled receptors, smells and identifies that plant as 
food (Dryer L 1999).  The animal then processes the smell and transmits electrical signals 
via ion channels across axons to move towards the plant.  Membrane proteins draw a 
huge amount of interest because of their integral roles in many essential processes.  As a 
result of their importance, ion channels and the superfamily of G-protein-coupled 
receptors (GPCRs) comprise a group of proteins that garner considerable interest from 
pharmaceutical companies. 
 
The objective is to overexpress three groups of eukaryotic membrane proteins in 
Escherichia coli.  The task poses several challenges considering the lack of an 
endoplasmic reticulum and a golgi apparatus, a dramatically different lipid composition, 
and completely different codon bias.  This chapter investigates the attempt to express and 
purify human voltage-gated potassium channel Kv1.5, G-protein coupled receptors, and 
MscS-like ion channels from Arabidopsis thaliana. 
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Background 
 
 
Human Voltage-Gated Potassium Channels 
 
 
In 1952, Hodgkin and Huxley proposed their membrane permeability mechanisms 
based on the giant squid axon (Hodgkin AL 1952).  However, not only until the 70s with 
voltage patch clamping did the molecular reasons start to be elucidated.  A significant 
event was the identification of sodium, potassium, and calcium channels that comprise 
the superfamily of voltage-gated potassium channels.  Much of this effort has focused on  
the six transmembrane spanning Shaker-like voltage-gated potassium channels.  The 
Shaker-like voltage-gated potassium channels represent a large and significant portion of 
the superfamily of voltage-gated ion channels. 
 
 
Fig. 5-1: Partial 
categorization of the 
mammalian six-
transmembrane voltage-
gated potassium 
channels, adapted from 
(Wei A 1996)).  Our 
focus centers around the 
Shaker-like potassium 
channels Kv1.1 to Kv1.7.  
Other members include 
the Eag/HERG, Ca2+ 
activated, and 
KCNQ/delayed rectifier 
channels. 
 
 
 
The basic biology of the Kv channels can be separated into three components: 
 93 
segment detecting a membrane depolarization and moving out across the membrane in 
response, thus opening the pore (Papazian DM 1991; Larrson HP 1996).  As a result of 
the concentration gradient, K+ ions move to the extracellular side and it is proposed that 
selectivity for potassium is conferred by the presence of carbonyl hydrogens that 
substitute for the waters of hydration around the ion (Doyle DA 1998).  The characteristic 
VGYG sequence provides for the size selectivity of the pore.  There are two mechanisms 
of inactivation, N-type and C-type.  The amino-terminal soluble domain or a separate "-
subunit carries out the N-type, or fast inactivation (MacKinnon R 1993; Rettig J 1994).  
A slow inactivation mode also is characterized in potassium channels, a process executed 
by portions of the C-terminus (Hoshi T 1991). 
 
The voltaged-gated potassium channels, closely similar to their sodium 
counterparts, are integral membrane proteins composed of six transmembrane helices 
with both the amino and carboxy termini in the cytoplasmic side.  The channel is 
generally described as having two major domains, a pore domain (S5–S6) sharing 
structural similarity with the Streptomyces lividans KcsA structure (Doyle DA 1998)  and 
a voltage-sensing domain (S1-S4).  X-ray structure data involving the S1-S4 domain is 
provided by the X-ray structure of the Aeropyrum pernix voltage-dependent potassium 
channel in complex with Fab fragments (Jiang Y 2003).  More recently, the structure of 
rat Kv1.2 complexed with Kv!2.1 was determined (Long SB 2005). 
 
Many potassium channels included in this subfamily are modulated by a variety 
of " subunits, which are not integral membrane proteins.  These coassemble with the # 
subunit.  The " subunit has an oxidoreductase activity and binds as a tetramer from the 
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cytoplasmic face of the core # channel.  There have only been a handful of voltage-
dependent ion channels characterized in prokaryotes.  These involve the 2 transmembrane 
segment LctB channel from Bacillus stearothermophilus (Wolters M 1999), the 6 
transmembrane segment Kch channel from Escherichia coli (Ungar D 2001), and the 6 
transmembrane spanning sodium channel NaChBac from Bacillus halodurans (Ren D 
2001).  Of course, the archaea A. pernix KvAP channel is included. 
 
Our research, through a collaboration with Merck Research Laboratories, 
primarily dealt with the human Shaker-like KCNA subfamily of voltage-dependent 
potassium channels.  There are nine known members, but work focused on the first 
seven.  The following chart details the seven potassium channels, their size range and 
differential expression in mammals.  I cloned and expressed seven human Kv channels in 
E. coli and demonstrated toxin binding in solution. 
 
TABLE 5-1 
Summary List of Human KCNA Channels 
Channel Gene ID Length MW kD Differential Expression 
hKv1.1 KCNA1 495 56.5 Brain 
hKv1.2 KCNA2 499 56.7 Lymphocyte 
hKv1.3 KCNA3 523 58.3 Lymphocyte, Skeletal Muscle 
hKv1.4 KCNA4 653 73.3 Skeletal Muscle, Heart 
hKv1.5 KCNA5 613 67.2 Heart, Skeletal Muscle 
hKv1.6 KCNA6 529 58.7 Brain 
hKv1.7 KCNA7 456 50.6 Skeletal Muscle, Heart, Kidney 
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Human G-Protein Coupled Receptors (GPCRs) 
 
 
 A significant step in research began twenty years ago with the cloning of the first 
G-protein-coupled receptors.  These are bovine rhodopsin (Nathans J 1983) and the 
mammalian !-adrenergic receptor (Dixon RA 1986).  A vast number of biochemical and 
biophysical studies have already been conducted on these receptors regarding structure 
and activation.  One key element of this superfamily of receptors is that they hold 
structural and functional homology.  Thus, information on any one of these ligand-gated 
GPCRs would provide invaluable insight applicable to other members of this family.  
  
 There are three distinct families of GPCRs.  Within each family approximately 
30% sequence similarity is shared mainly in the seven conserved transmembrane regions.  
The proposed research focuses on Family A, the largest group consisting of the 
rhodopsins, adrenergic, olfactory, serotonin, histamine, dopamine receptors and others.  
Despite the ever growing number of protein crystal structures, membrane protein 
structures represent an small subpopulation.  The knowledge and techniques surrounding 
these approaches have improved.  In 2000, the structure of bovine rhodopsin was 
determined at 2.8 A, providing an unprecedented increase in knowledge of GPCR 
structure (Palczewski K 2000).  Very recently, structures of the human !-adrenergic 
receptor have been determined (Cherezov V 2007; Rasmussen SG 2007).  Still, much 
remains unclear, especially regarding the mechanical basis of ligand-gated receptor 
activation and signal transduction.  The medical significance of GPCRs necessitates 
further studies that will explore the ligand binding interaction and activation mechanism. 
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Fig. 5-2:  The membrane 
topology of GPCRs.  GPCRs 
are integral membrane 
proteins ranging in size from 
300–1000 amino acids.  
Hydrophobicity analysis of 
the GPCRs reveal the 
presence of 7 hydrophobic 
regions predicted to form 
membrane-spanning "-
helices, suggesting a similar 
structural arrangement for 
this superfamily of proteins.  
Several amino acids in the 
hydrophobic domains are 
highly conserved amongst the 
GPCRs, implicating their role 
in folding.  Other conserved 
amino acids conserved within 
families are thought to confer 
binding specificity for a 
ligand class. 
 
 
 
 
Drugs that target GPCRs include widely used therapeutics such as 
antihypertensive, antipsychotic agents, opioid analgesics, and allergy medicine.  Despite 
an already massive number of existing drugs, there is an incessant need to design new 
and improved pharmacological agents.  The pharmaceutical discovery field has long 
suggested the possibility of rational drug design based on three-dimensional structures of 
drug targets.  However, due to the paucity of high-resolution structures of these receptors, 
methods to design agonists and antagonists rely primarily on combinatorial chemistry.  
As such, the crystal structure of a ligand-gated GPCR is a critical step in not only 
understanding signal transduction but also the application of rational drug discovery. 
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GPCRs are integral membrane proteins consisting of a seven-transmembrane 
domain bundle with significant and variable N-terminal and C-terminal domains.  These 
proteins are ubiquitously expressed in eukaryotes.  GPCRs act by transducing external 
signals into cells via activation of intracellular G proteins.  The similarities between 
members of this superfamily are supported by the conservation of specific regions of the 
receptor.  The superfamily of G-protein-coupled receptors hold a wealth of information 
regarding the signaling pathways in basic physiology.  GPCRs are known to interact with 
many proteins that modulate signal transduction.  The regulatory cycles, fundamental 
GPCR structure and function remain poorly understood. 
 
There are many challenges of overexpressing eukaryotic membrane proteins in 
bacteria.  Oftentimes, the expressed protein can have an inherent cytotoxicity.   Also, the 
changes in post-translational modification machinery or lack thereof could adversely 
effect the goal of producing folded and stable protein.  Reports of expressing ligand-
binding human opioid receptor in bacteria demonstrated expression levels on the order of 
10–70 receptors per cell, values similar to other attempts in overexpressing GPCRs in 
bacteria (Grisshammer R 1995; Stanasila L 1999).  These cases are encouraging in that 
functional eukaryotic protein can be produced.  However, the expression level suggests 
that low protein output can be due to toxicity of GPCR expression or lack of the post-
translational modifications present in eukaryotic expression systems.  A comprehensive 
approach to the expression of 15 human GPCRs in E. coli was attempted and resulted in 
the successful production of 4 of the target genes. 
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MscS-Like (MSL) Ion Channels from Arabidopsis thaliana 
 
 
The mechanosensitive channel of large conductance (MscL) and small 
conductance (MscS) have been characterized as stretch-activated channels that open with 
sufficient increased membrane tension in order to prevent rupture during hypoosmotic 
shock.  MscS homologs are prevalent in bacterial and archaeal species and more recently 
MscS-like proteins have been found in Arabidopsis thaliana.  These MscS-like proteins, 
MSL2 and MSL3 have been demonstrated to rescue osmotic downshock resistance in a 
E. coli strain that lack endogenous the mechanosensitive channels MscL, MscS, and 
MscK (Haswell ES 2006).  MSL2 and MSL3 fusion proteins with green fluorescent 
protein (GFP) were shown to localize to discrete foci on the plastid envelope.  These two 
fusion proteins were also demonstrated to co-localize with proteins that participate in the 
plastid division machinery.  Insertional mutants that 
disrupt the production of endogenous MSL2 and 
MSL3 result in plants with plastid abnormalities in 
shape and size. 
 
 The identification of MscS-like proteins was 
carried out by BLASTP with homology with almost 
exclusively the third transmembrane helix and the 
middle !-domain in Escherichia coli MscS.  With 
nearly nonexistent biochemical and structural data 
regarding this family of proteins, determining the 
crystal structure of an MSL protein would provide a 
 
Fig. 5-3:  MscS Structure (PDB 
2OAU) with region of MSL 
homology colored in orange.  
Figure created using the program 
PYMOL. 
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considerable amount of information regarding changing ion flux in response to sensing 
membrane stretch.  I attempted to clone, express, and purify MSL2 and MSL3 with and 
without their signal sequences.  These signal sequences, thought to direct the protein to 
the chloroplast, are typically cleaved in the mature protein. 
 
Experimental Procedures 
 
 
Cloning and Expression of Mammalian Kv Channels and !DTX 
 
 
The mammalian Kv channels 1.1 to 1.7 are amplified by PCR and inserted into a 
modified Novagen pET28b(+) vector with an N-terminal decahistidine affinity tag via the 
Nde1 and BamH1 restriction sites.  The plasmid corresponding to each channel is 
transformed into BL21Gold (DE3) cells.  Expression is conducted in a 60 L fermentor in 
a modified medium grown to an OD600 of 2 at 37°C.  The solution is cooled to 30°C, 
induced with 1% lactose and 1 mM IPTG for 1 hour and is harvested.  $-dendrotoxin is 
produced as a c-terminal fusion with the Cap9 protein in the standard Novagen 
pET28b(+) vector.  A trypsin proteolytic cleavage site is present just prior to the start of 
the $-dendrotoxin gene. 
 
Purification of Mammalian Kv Channel 
 
 
Scale-up of potassium channels involves a 60 L growth in an 80 L BioFlo 5000# 
fermentor (New Brunswick, NJ).  100 g of cell paste is thawed out in a total volume of 
400 mL using Kv Buffer A.  Mechanical homogenization can be used to facilitate this 
process.  Next, 1% (w/v) Fos-choline 14 (FC14) is added and dissolved at 4°C with the 
help of a stir bar.  Cell lysis is then conducted through three cycles of the M-110L 
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Microfluidizer# processor (Microfluidics, MA).  The cell lysate is stirred at 4°C for an 
additional hour to ensure 
maximal solubilization.  The 
mixture is centrifuged 
(Beckmann, rotor JA-14, 
30,1000 x g, 60 min, 4°C).  
The supernatant is carefully 
removed without disturbing 
the pellet. 
 
All chromatography 
is conducted on an AKTA 
Explorer (GE Lifesciences, 
NJ).  The supernatant is 
applied to a chromatography 
column containing 100 mL 
Ni-NTA Superflow (Qiagen, 
CA) that is equilibrated with 
Kv Buffer B1.  After 
loading, the column is washed with 100% Kv Buffer B1 until the 280 nm trace 
approaches baseline.  At that point, the column is washed with 200 mL of 5% Kv Buffer 
B2, 95% Kv Buffer B1.  Eluting the column requires 54% Kv Buffer B2, 46% Kv Buffer 
B1.  200 mL of the eluate, when the chromatograph deflects upwards, is collected.  The 
process can be repeated with the flowthrough to maximize capture of protein. 
 
 
 
Fig. 5-4:  Top:  
Standard 100 g 
elution from 
Ni2+ affinity 
chromatography 
of hKv1.5  
using 100 mL 
of resin.  
Middle:  
Standard size 
exclusion 
chromatography 
using a 26/60 
Sephacryl-300 
column.  
Bottom:  This 
coommassie-
stained SDS-
PAGE gel of 1 
µL final sample 
indicates both 
the purity and 
approximate 
concentration 
(~10 mg/L) of 
hKv1.5 
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The eluate is then desalted on a HiPrep 26/10 desalting column using Kv Buffer 
C.  The desalted protein is then loaded onto a Source 30Q column that is equilibrated 
with Kv Buffer E1.  A gradient is run at 2 mL/min from 100% Kv Buffer E1:0% Kv 
Buffer E2 to 0% KvBuffer E1:100% Kv Buffer E2 over 60 minutes while collecting 
fractions.  The peak of interest is then concentrated in a 100 kDa cutoff Amicon$-Ultra-
15 centrifugal filter device (Millipore, MA) to approximately 2 mL. A 26/60 HiPrep 
Sephacryl 300 HR column (GE Lifesciences, NJ) is equilibrated with 400 mL of Kv 
Buffer D.  The protein is then injected and run at 0.5 mL/min while collecting 3 mL 
fractions between 110 mL and 170 mL.  Visualizing the peak fractions by SDS-PAGE is 
used to identify those fractions for concentrating. 
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TABLE 5-2 
Buffers Used in the Purification of Potassium Channels 
Kv Buffer A 50 mM Tris pH 7.5 
200 mM KCl 
30 mM imidazole pH 
7.5 
2 mM MgCl2 
protease inhibitor tablets 
0.1 mM PMSF 
0.05 mg/mL DNAse 
0.2 mg/mL lysozyme 
Kv Buffer B1 20 mM Tris pH 7.5 
500 mM KCl 
30 mM imidazole pH 7.5 
0.05% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
 
Kv Buffer B2 20 mM Tris pH 7.5 
500 mM imidazole pH 
7.5 
0.05% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
Kv Buffer C 20 mM Tris pH 7.5 
20 mM KCl 
0.005% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
Kv Buffer D 20 mM Tris pH 7.5 
150 mM KCl 
0.005% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
Kv Buffer E1 20 mM Tris pH 7.5 
20 mM KCl 
0.05% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
Kv Buffer E2 100 mM Glycine pH 3.5 
1000 mM KCl 
0.05% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
  
 
 
Characterization of the Kv1.5 Binding to !-Dendrotoxin 
 
 
The Eastern Green Mamba Dendroaspis angusticeps produces $-Dendrotoxin ($-
DTX) is a 7.6 kD protein that is 60 amino acid residues in length and contains three 
disulfide bridges.  Despite nanomolar affinity to some Kv1 channels, $-DTX binds the 
wildtype hKv1.5 channel with only micromolar affinity.  However, still with the 
particular interest in the hKv1.5 channel, Merck Research Laboratories utilized the 
energetic and structural data involving the interactions between $-DTX and the Shaker 
channel to make a single point mutation R485Y that increased the binding affinity by 
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three orders of magnitude (Imredy JP 2000).  $-DTX was coupled via primary amines to 
CNBr-activated Sepharose 4B.  Purified Kv1.5 R485Y was incubated with the resin and 
the protein was eluted by washing the resin with dithiothreitol (DTT).  
 
Cloning of Human G-Protein Coupled Receptors (GPCRs) 
 
 
 Twelve genes encoding GPCRs were amplified by PCR from genomic DNA 
obtained from the Guthrie cDNA Resource Center (http://www.guthrie.org) using two 
primers both 
containing unique 
restriction sites and 
sequences 
complementary to the 
gene of interest.  The 
primers utilized are 
detailed in Table 5-4.  
The 3’ primer used 
for building the 
pET28b(+) and pET26b(+) constructs are the same and the 5’ Primer is used for pET19b, 
pET26b(+), and pET28b(+).  Lastly, the number of the oligonucleotides in Table 5-4 
corresponds to the GPCR number in Table 5-3.  The amplified PCR product was digested 
for 2 hours at 37°C with 10 units of the appropriate restriction enzyme (NEB, MA) and 
gel purified using a gel extraction kit (Qiagen, CA).  The digested insert was then ligated 
overnight into a the target vector (pET19b, pET26b(+), pET28b(+), and/or pMAL.p2E).  
TABLE 5-3 
Summary List of Attempted GPCRs 
Gene # Gene ID Description 
1 HRH1 Histamine Receptor 1 
2 HRH2 Histamine Receptor 2 
3 BAR2 !2 Adrenergic Receptor 
4 A1A "1A Adrenergic Receptor 
5 A1B "1B Adrenergic Receptor 
6 HTR1A Serotonin Receptor 1A 
7 HTR2A Serotonin Receptor 2A 
8 DRD1 Dopamine Receptor D1 
9 OPRK ( Opioid Receptor 
10 FSHR Follicle Stimulating Hormone Receptor 
11 MC1R Melanocorton Receptor 1 
12 TBXA2 Thromboxane Receptor 2 
13 M1 Muscarinic Receptor 1 
14 M2 Muscarinic Receptor 2 
15 CCR3 Chemokine Receptor 3 
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The set of plasmids differed in tag location and linker length, while also testing effect of 
the pelB secretion signal and the expression of the GPCR as a fusion protein with the 
maltose binding protein (MBP).  
 
TABLE 5-4 
Primers Designed for the Amplification of GPCRs 
Gene 
#/Primer 
Primer 
Description 
Sequence 
1A 5’ Primer GCA ACT TGG CAT ATG AGC CTC CCC AAT TCC 
1B 3’ pET19b GTA AGC TAG CTC GAG TTA GGA GCG AAT ATG CAG 
1C 3’ pET28b(+) GTA AGC TAG CTC GAG GGA GCG AAT ATG CAG AAT 
1D 5’ pMAL.p2E GCA ACT TGG TGA TCA ATG AGC CTC CCC AAT TCC 
1E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCG GAG CGA ATA TGC AGA AT 
   
2A 5’ Primer GCA ACT TGG CAT ATG GCA CCC AAT GGC ACA 
2B 3’ pET19b GTA AGC TAG CTC GAG TTA CCT GTC TGT GGC TCC 
2C 3’ pET28b(+) GTA AGC TAG CTC GAG CCT GTC TGT GGC TCC CTG 
2D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG GCA CCC AAT GGC ACA 
2E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC CTG TCT GTG GCT CCC TG 
   
3A 5’ Primer GCA ACT TGG CAT ATG GGG CAA CCC GGG AAC 
3B 3’ pET19b GTA AGC TAG CTC GAG TTA CAG CAG TGA GTC ATT 
3C 3’ pET28b(+) GTA AGC TAG CTC GAG CAG CAG TGA GTC ATT TGT 
3D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG GGG CAA CCC GGG AAC 
3E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC AGC AGT GAG TCA TTT GT 
   
4A 5’ Primer GCA ACT TGG CAT ATG GTG TTT CTC TCA GGA 
4B 3’ pET19b GTA AGC TAG CTC GAG CTA GAC TTC CTC CCC GTT 
4C 3’ pET28b(+) GTA AGC TAG CTC GAG GAC TTC CTC CCC GTT CTC 
4D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG GAT GTG CTC AGC CCT 
4E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC TGG CGG CAG AAC TTA CA 
   
5A 5’ Primer GCA ACT TGG CAT ATG AAT CCC GAC CTG GAC 
5B 3’ pET19b GTA AGC TAG GTC GAC CTA AAA CTG CCC GGG CGC 
5C 3’ pET28b(+) GTA AGC TAG GTC GAC AAA CTG CCC GGG CGC CAG 
5D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG GAT ATT CTT TGT GAA 
5E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC ACA CAG CTC ACC TTT TC 
   
6A 5’ Primer GCA ACT TGG CAT ATG GAT GTG CTC AGC CCT 
6B 3’ pET19b GTA AGC TAG CTC GAG TCA CTG GCG GCA GAA CTT 
6C 3’ pET28b(+) GTA AGC TAG CTC GAG CTG GCG GCA GAA CTT ACA 
   
7A 5’ Primer GCA ACT TGG CAT ATG GAT ATT CTT TGT GAA 
7B 3’ pET19b GTA AGC TAG CTC GAG TCA CAC ACA GCT CAC CTT 
7C 3’ pET28b(+) GTA AGC TAG CTC GAG CAC ACA GCT CAC CTT TTC 
   
8A 5’ Primer GCA ACT TGG CAT ATG AGG ACT CTG AAG ACC 
8B 3’ pET19b GTA AGC TAG CTC GAG TCA GGT TGG GTG CTG ACC 
8C 3’ pET28b(+) GTA AGC TAG CTC GAG GGT TGG GTG CTG ACC GTT 
8D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG AGG ACT CTG AAC ACC 
8E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCG GTT GGG TGC TGA CCG TT 
 105 
   
9A 5’ Primer GCA ACT TGG CAT ATG  GAC TCC CCG ATC CAG 
9B 3’ pET19b GTA AGC TAG CTC GAG TCA TAC TGG TTT ATT CAT 
9C 3’ pET28b(+) GTA AGC TAG CTC GAG TAC TGG TTT ATT CAT CCC 
9D 5’ pMAL.p2E GCA ACT TGG GGC CCA GCC GGC CAT GGA CTC CCC GAT 
CCA G 
9E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCT ACT GGT TTA TTC ATC CC 
   
10A 5’ Primer GCA ACT TGG CAT ATG GCC CTG CTC CTG GTC 
10B 3’ pET19b GTA AGC TAG CTC GAG TTA GTT TTG GGC TAA ATG 
10C 3’ pET28b(+) GTA AGC TAG CTC GAG GTT TTG GGC TAA ATG ACT 
10D 5’ pMAL.p2E GCA ACT TGG TGA TCA ATG GCC CTG CTC CTG GTC 
10E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCG TTT TGG GCT AAA TGA CT 
   
11A 5’ Primer GCA ACT TGG CAT ATG GCT GTG CAG GGA TCC 
11B 3’ pET19b GTA AGC TAG CTC GAG TCA CCA GGA GCA TGT CAG 
11C 3’ pET28b(+) GTA AGC TAG CTC GAG CCA GGA GCA TGT CAG CAC 
11D 5’ pMAL.p2E GCA ACT TGG AGA TCT ATG GCT GTG CAG GGA TCC 
11E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC CAG GAG CAT GTC AGC AC 
   
12A 5’ Primer GCA ACT TGG CAT ATG TGG CCC AAC GGC AGT 
12B 3’ pET19b GTA AGC TAG CTC GAG TCA ATC CTT TCT GGA CAG 
12C 3’ pET28b(+) GTA AGC TAG CTC GAG ATC CTT TCT GGA CAG AGC 
   
13A 5’ Primer GCA ACT TGG CAT ATG AAC ACT TCA GCC CCA 
13B 3’ pET19b GTA AGC TAG CTC GAG TCA GCA TTG GCG GGA GGG 
13C 3’ pET28b(+) GTA AGC TAG CTC GAG GCA TTG GCG GGA GGG AGT 
13D 5’ pMAL.p2E GCA ACT TGG GGA TCC ATG AAC ACT TCA GCC CCA 
13E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCG CAT TGG CGG GAG GGA GT 
   
14A 5’ Primer GCA ACT TGG CAT ATG AAT AAC TCA ACA AAC 
14B 3’ pET19b GTA AGC TAG CTC GAG TTA CCT TGT AGC GCC TAT 
14C 3’ pET28b(+) GTA AGC TAG CTC GAG CCT TGT AGC GCC TAT GTT 
14D 5’ pMAL.p2E GCA ACT TGG AGA TCT ATG AAT AAC TCA ACA AAC 
14E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCC CTT GTA GCG CCT ATG TT 
   
15A 5’ Primer GCA ACT TGG CAT ATG ACA ACC TCA CTA GAT 
15B 3’ pET19b GTA AGC TAG CTC GAG CTA AAA CAC AAT AGA GAG 
15C  3’ pET28b(+) GTA AGC TAG CTC GAG AAA CAC AAT AGA GAG TTC 
15D 5’ pMAL.p2E GCA ACT TGG TGA TCA ATG ACA ACC TCA CTA GAT 
15E 3’ pMAL.p2E GTA AGC TAG GCG GCC GCA AAC ACA ATA GAG AGT TC 
 
 
Expression Screening of GPCRs 
 
  
The GPCRs underwent extensive expression screening involving a matrix of 
variables that included the different plasmids, strains, growth temperatures, induction 
conditions, and growth media.  The strains attempted included BL21 Gold (DE3), BL21 
CodonPlus (DE3), RosettaBlue (DE3), C41 (DE3), and C43 (DE3).  Growths were 
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attempted at room temperature (~ 25°C), 30°C, and 37°C.  It has been observed that 
bacterial membranes grown at 37°C have an unsaturated to saturated fatty acid ratio of ~ 
1 whereas bacteria grown at 20°C results in a fatty acid ratio of ~ 2.  The latter more 
closely resembles the ratio of eukaryotic membranes, which might be a more appropriate 
membrane system for the production of human GPCRs (Dowhan 1997).  The media 
screen that was developed (Appendix A) has been instrumental in the expression of 
several membrane proteins that have been traditionally hard to express.  The screen 
involves substituting malt and beef extract for the standard yeast extract in TB (Terrific 
Broth). 
 
Purification of GPCRs 
 
 
 After the identification of the growth conditions for a particular GPCR, scale-up 
involves a 60 L growth in an 80 L BioFlo 5000# fermentor (New Brunswick, NJ).  200 g 
of cell paste is thawed out in a total volume of 400 mL using GPCR Buffer A.  
Mechanical homogenization can be used to facilitate this process.  Next, 1% (w/v) Fos-
choline 14 (FC14) is added and dissolved at 4°C with the help of a stir bar.  Cell lysis is 
then conducted through three cycles of the M-110L Microfluidizer# processor 
(Microfluidics, MA).  The cell lysate is stirred at 4°C for an additional hour to ensure 
maximal solubilization.  The mixture is centrifuged (Beckmann, rotor JA-14, 30,1000 x 
g, 60 min, 4°C).  The supernatant is carefully removed without disturbing the pellet. 
 
All chromatography is conducted on an AKTA Explorer (GE Lifesciences, NJ).  
The supernatant is applied to a chromatography column containing 100 mL Ni-NTA 
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Superflow (Qiagen, CA) that is equilibrated with GPCR Buffer B1.  After loading, the 
column is washed with 100% GPCR Buffer B1 until the 280 nm trace approaches 
baseline.  At that point, the column is washed with 200 mL of 5% GPCR Buffer B2, 95% 
GPCR Buffer B1.  Eluting the column requires 54% GPCR Buffer B2, 46% GPCR 
Buffer B1.  200 mL of the eluate, when the chromatograph deflects upwards, is collected.  
The process can be repeated with the flowthrough to maximize capture of protein. 
 
The eluate is then concentrated in a 100 kDa cutoff Amicon$-Ultra-15 
centrifugal filter device (Millipore, MA) down to approximately 2 mL. A 26/60 HiPrep 
Sephacryl 300 HR column (GE Lifesciences, NJ) is equilibrated with 400 mL of GPCR 
Buffer C.  The protein is then injected and run at 0.5 mL/min while collecting 4 mL 
fractions between 90 mL and 240 mL.  Visualizing the peak fractions by SDS-PAGE is 
used to identify those fractions for concentrating. 
 
TABLE 5-5 
Buffers Used in the Purification of GPCRs 
GPCR Buffer A 50 mM Tris pH 7.5 
20 mM NaCl 
30 mM imidazole pH 
7.5 
2 mM MgCl2 
protease inhibitor 
tablets 
0.1 mM PMSF 
0.05 mg/mL DNAse 
0.2 mg/mL lysozyme 
GPCR Buffer 
B1 
20 mM Tris pH 7.5 
500 mM NaCl 
30 mM imidazole pH 7.5 
0.05% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
 
GPCR Buffer 
B2 
20 mM Tris pH 7.5 
500 mM imidazole pH 
7.5 
0.05% FC14 
protease inhibitor 
tablets 
0.1 mM PMSF  
GPCR Buffer C 20 mM Tris pH 7.5 
150 mM NaCl 
0.005% FC14 
protease inhibitor tablets 
0.1 mM PMSF 
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Cloning of MscS-Like Ion Channels from Arabidopsis thaliana 
 
 
The goal was to produce the MSL protein in a pET28b(+) vector with a C-
terminal FLAG epitope tag.  The gene was generously provided by the Meyerowitz lab, 
Caltech.  The cloning strategy involves utilizing the pET28b(+) hexahistidine tag that is 
upstream of the multiple cloning site and introducing a Flag epitope tag through the 
antisense primer.  MSL1, its cleaved version MSL1-CL, MSL3, and its cleaved version 
MSL3-CL takes advantage of the plasmid’s Nde1 and EcoR1 restriction sites.  MSL2 and 
its cleaved version MSL2-CL posed a challenge because of an endogenous Nde1 
restriction site.  Using a BspH1 restriction site allowed us to circumvent that problem, 
however it was necessary to reintroduce the heptahistidine tag in the coding primer. 
 
The amplified PCR product was digested for 2 hours at 37°C with 10 units of 
either Nde1 and EcoR1 or BspH1 and EcoR1 restriction enzyme (NEB, MA) and gel 
purified using a gel extraction kit (Qiagen, CA).  The digested insert was then ligated 
overnight into a pET28b(+) vector digested in the presence of calf intestinal alkaline 
phosphatase with the same enzymes at 16°C with 1 unit of T4 ligase (NEB, MA).  
Plasmids from single colonies are isolated for sequence confirmation. 
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TABLE 5-6 
Primers Designed for the Amplification  of MscS-Like (MSL) Proteins 
Gene 5’ Restriction 
Enzyme 
5’ Primer Sequence 3’ Restriction 
Enzyme 
3’ Primer Sequence 
MSL1 5’Nde1 GTCCGACATATGG
CCGGAGTTAGGTT
ATCG 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCCATCGTCCT
TGTAGTCGCCCAATGT
AGAATTGTCCCA 
 
MSL1CL 5’Nde1 GTCCGACATATGG
GAAGTATTGTAGC
CTCT 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCCATCGTCCT
TGTAGTCGCCCAATGT
AGAATTGTCCCA 
 
MSL2 5’BspH1 GTCCGATCATGAG
CAGCAGCCATCAT
CATCATCATCACC
ACAGCAGCGGCCT
GGTGCCGCGCGGC
AGCATGGCCCTTT
ATGGTACATTG 
 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCATCGTCCTT
GTAGTCGCCCGGCTCG
GTTGAAGCACC 
MSL2CL  5’BspH1 GTCCGATCATGAG
CAGCAGCCATCAT
CATCATCATCACC
ACAGCAGCGGCCT
GGTGCCGCGCGGC
AGCATGTGTCATT
CCTTTTCTGCA 
 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCATCGTCCTT
GTAGTCGCCCGGCTCG
GTTGAAGCACC 
MSL3 5’Nde1 GTCCGACATATGC
GTACTGTTGCTTTA
CCA 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCATCGTCCTT
GTAGTCGCCTTCTGATC
CAATACCAAG 
 
MSL3CL 5’Nde1 GTCCGACATATGT
GTAATGCATTTGTT
TGC 
3’EcoR1 TCGGACGAATTCTCAC
TTGTCGTCATCGTCCTT
GTAGTCGCCTTCTGATC
CAATACCAAG 
 
 
Expression and Expression Optimization of MSLs 
 
 
Plasmids pET28b(+).MSL1.FT, pET28b(+).MSL1CL.FT, pET28b(+).MSL2.FT, 
pET28b(+).MSL2CL.FT, pET28b(+).MSL3.FT, and pET28b(+).MSL3CL.FT are 
transformed into BL21 Gold (DE3) cells (Stratagene) for expression trials.  Highest 
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expression was observed with MSL1 and MSL3CL; while expression of MSL2 was seen, 
significant degradation was also present. 
 
Initial expression testing involved the utilization of BL21 Gold (DE3) cells, 
grown at 37°C, in LB supplemented with 50 µg/mL kanamycin sulfate.  Expression was 
observed from the MSL1 and MSL3CL constructs.  MSL2 expressed as well (data not 
shown), however with significant degradation, as observed by Western blot.  Expression 
of MSL1 and MSL3CL was then further optimized using the media screen as described in 
Appendix A, along with strain and growth temperature.  
 
Purification of MSL1 and MSL3CL 
 
 
The pET28b(+).MSL1.FT plasmid was transformed into BL21 Gold (DE3) cells 
and grown at room temperature in 4L of GM1.  Cells at OD600 ~ 2 were induced with 1 
mM IPTG for 1 hour and subsequently harvested in a centrifuge.  The 
pET28b(+).MSL3CL.FT plasmid was transformed into BL21 Codon Plus RIPL (DE3) 
cells and grown at room temperature in 4L of GM6.  Cells at OD600 ~ 2 were induced 
with 1 mM IPTG for 1 hour and subsequently harvested in a centrifuge.   
 
20 g of cell paste is thawed out in a total volume of 100 mL using MSL Buffer A.  
Mechanical homogenization is sometimes used to facilitate this process.  1% (w/v) decyl-
!-D-maltopyranoside (DM) is added for  MSL1 or 1% (w/v) fos-choline 14 (FC14) is 
added for MSL3CL and dissolved at 4°C with the help of a stir bar.  Cell lysis is then 
conducted via sonication.  The cell lysate is stirred at 4°C for an additional hour to ensure 
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maximal solubilization.  Then, the mixture is centrifuged in a JA-14 rotor at 30,100 x g 
for 1 hour at 4°C.  The supernatant is carefully removed without disturbing the pellet. 
 
All chromatography is conducted on an AKTA Explorer (GE).  The supernatant is 
applied to a chromatography column containing 4 mL Ni2+-Sepharose Superflow (GE) 
that is equilibrated with MSL Buffer B1.  After loading, the column is washed with 100% 
MSL Buffer B1 until the Abs280 approaches baseline.  At that point, the column is 
washed with 60 mL of 5% MSL Buffer B2, 95% MSL Buffer B1.  Eluting the column 
requires 54% MSL Buffer B2, 46% MSL Buffer B1.  Elution begins when the 
chromatograph deflects upwards.  Approximately 30 mL of the eluate was collected. 
 
The eluate is then applied to a 10 mL Flag antibody column that is equilibrated 
with MSL Buffer C1.  After loading is complete, 100% MSL Buffer C1 is used to wash 
the column until the 280 nm trace reaches baseline.  100% MSL Buffer C2 is then 
applied to elute the protein.  The protein is eluted as 7 mL fractions into tubes already 
containing 2 mL of 1.0 M Tris pH 8.0.  After elution is complete, the column is 
equilibrated with 100% MscS Buffer C1.  The flag eluate is concentrated in 100 kDa 
cutoff filter concentrators (Amicon Ultra) to approximately 250 µL.  Samples were taken 
for SDS-PAGE at various chromatography steps to characterize the purification (Figure 
5-8). 
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TABLE 5-7 
Buffers used to purify MscS-like (MSL) Proteins 
MSL Buffer 
A 
20 mM Tris pH 7.5 
20 mM NaCl 
30 mM imidazole pH 7.5 
2 mM MgCl2 
protease inhibitor tablets 
0.1 mM PMSF 
0.05 mg/mL DNAse 
0.2 mg/mL lysozyme 
MSL Buffer 
B1 
20 mM Tris pH 7.5 
500 mM NaCl 
30 mM imidazole pH 7.5 
0.05% Detergent 
protease inhibitor tablets 
0.1 mM PMSF 
 
MSL Buffer 
B2 
20 mM Tris pH 7.5 
500 mM imidazole pH 7.5 
0.05% Detergent 
protease inhibitor tablets 
0.1 mM PMSF 
MSL Buffer 
C1 
20 mM Tris pH 7.5 
150 mM NaCl 
0.05% Detergent 
protease inhibitor tablets 
0.1 mM PMSF 
MSL Buffer 
C2 
100 mM Glycine pH 3.5 
150 mM NaCl 
0.05% Detergent 
protease inhibitor tablets 
0.1 mM PMSF 
  
 
 
Results 
 
 
Characterization of the Kv1.5 Binding to !-Dendrotoxin 
 
 
Experiments 
conducted involving 
the $-DTX conjugated 
resin demonstrated 
that hKv1.5 R485Y in 
fact binds the toxin in 
solution.  Further 
studies were carried 
out to determine the 
 
SDS-PAGE Loading 
Order 
1) Purified hKv1.5 
R485Y in FC14 
2) DTX column 
flowthrough 
3) Wash 1 
4) Wash 2 
5) Eluate 1 
6) Eluate 2 
7) Blank 
8) Concentrate Eluate 
Fig. 5-5:  Example of  $-DTX binding by hKv1.5 R485Y that 
is purified using FC14.  Elution of hKv1.5 R485Y was enabled 
by the addition of 10 mM DTT. 
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dependence of the DTX-binding capability on the detergent micelle.  It has been shown 
that in general, the maltopyranoside nonionic detergents faired better than the lipid-like 
zwitterionic  Fos-Choline detergents.  In both classes of detergents, shorter carbon tails 
also improved binding.  Fos-Choline 10, 12, and 14 binding between the channel and 
DTX could be brought to the levels of the maltopyranosides upon the addition of a cymal 
detergent.  Due to extraction capability and the levels required to purify, a combination 
between Fos-Choline 12 and Cymal-3 has been used as the optimized condition to 
maximize binding.  However, the unfortunate consequence of using DTT to elute the 
protein is that the refolding $-DTX on the column is not completely efficient.  As a result, 
the performance of the column between uses decreases precipitously.   
 
G-Protein Coupled Receptors 
 
Successful expression of four GPCRs was achieved in relatively different 
expression conditions involving the vector, strain used in expression, growth medium, 
and growth temperature.  These data are summarized in Table 5-8. 
 
 
 
 
 
 
 
 
TABLE 5-8 
Summary Table of Successfully Expressed GPCRs 
Receptor Vector Strain Medium Temperature 
Opioid, Kappa pET26b(+) RosettaBlue(DE3) GM-5 30 C 
Opioid, Kappa pMal-p2E C41 (DE3) TB 30 C 
Histamine 1 pMal-p2E RosettaBlue(DE3) TB 30 C 
Melanocortin 1 
Receptor 
pMal-p2E RosettaBlue(DE3) GM-5 30 C 
Serotonin 1A pMal-p2E All strains TB 30 C 
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Purification of OPRK  
 
 
 Obstacles in protein 
purification include issues of 
stability, detergent 
preference, buffer systems, 
de-lipidation, and 
homogeneity.  The 
purification and 
characterization of GPCRs 
expressed in Escherichia 
coli was focused primarily 
on two opioid receptor 
constructs: 
pET26b(+).OPRK and pMAL-p2E.OPRK.  The pET26b(+).OPRK-derived protein was 
purified using a Ni2+-NTA column and a subsequent gel filtration column.   It is 
interesting to note the behavior of OPRK on the size exclusion column.  The various 
oligomers seen on SDS-PAGE are not gel artifacts, but instead they are stable oligomers.  
The monomer from gel filtration was isolated and found to be stable for at least 7 days.  
The monomer OPRK did not redistribute and form oligomers.  The purification of the 
pMAL-p2E.OPRK-derived protein was carried out in a similar fashion, however, with the 
added step of removing the maltose binding protein from the N-terminus via proteolytic 
digest using enterokinase. 
 
 
 
Fig. 5-6:  
Purification of 
pET26b(+).OP
RK.  Top:  
Fractions from 
Ni2+-NTA 
purification 
using FC-14.  
Bottom:  Size 
exclusion 
chromatography 
separates 
oligomers.  
Isolation of the 
monomer is 
stable for at 
least 7 days 
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Expression of MSL Channels 
 
 
The MSL plasmids were transformed into BL21Gold (DE3) for preliminary 
expression testing.  The trials with MSL1, 2 and 3 with and without the endogenous 
signal sequence yielded mixed results.  Attempts to produce MSL1-CL and MSL3 failed 
whereas MSL2 and MSL2-CL expression was accompanied by a significant amount of 
degradation.  Positive results with MSL1 and MSL3-CL prompted progression into the 
expression optimization matrix where temperature, strain, and growth media are 
screened.  Figure 5-7 summarizes the optimization. 
 
  
   
Fig. 5-7:  The screening of strains, temperature, and growth media can 
significantly affect the ability to express eukaryotic membrane proteins in 
Escherichia coli.  Top: Optimization of MSL1 results in expression in the 
BL21Gold (DE3) strain at 25°C using Growth Medium 1 (GM1).  Bottom: 
Optimization of MSL3-CL results in expression in the  BL21 Codon Plus 
RIPL (DE3) strain at 25°C using Growth Medium 6 (GM6). 
 
 
 116 
Purification of MSL1 and MSL3-CL 
 
 
Purification of the two proteins, MSL1 and MSL3-CL, is enabled through the 
engineered hexahistidine and Flag epitope tags.  Initial purification studies were 
conducted using decyl-!-D-maltopyranoside (DM) for MSL1 and fos-choline 14 (FC14) 
for MSL3-CL.  These trials were performed on isolated membranes.  Although visible on 
a Western immunoblot, the purification of MSL1 yielded only a small amount of purified 
protein.  On the other hand, the purification of MSL3-CL produced a significant amount 
of highly pure protein (Figure 5-8). 
 
  
Fig. 5-8:  Left: "-His Western immunoblot showing the purification of MSL1 
using a Ni2+-NTA column followed by a Flag antibody column.  Purified MSL1 is 
circled in white.  Right:  SDS-PAGE with coomassie stain showing the 
purification of MSL3-CL using a Ni2+-NTA column followed by a Flag antibody 
column.  Purified MSL3-CL is circled in white. 
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Discussion 
 
 
 Expression of eukaryotic membrane proteins in Escherichia coli is typically met 
with a series of challenging obstacles.  Fundamental differences in bacteria and 
eukaryotic organisms involve membrane-bound organelles, the post-translational 
modification machinery, and the basic translocation pathway that requires the recognition 
of sequences that hold the molecular determinants of protein translocation.  Oftentimes, 
the membrane protein of interest is inherently cytotoxic, resulting in the protein 
degradation, production of inclusion bodies, or even cell death. 
 
 This chapter has recounted three attempts at overexpressing eukaryotic membrane 
proteins in E. coli for the purpose of accumulating large amounts of purified protein to 
conduct crystallization trials.  I was able to produce all  human Shaker-like voltage-gated 
potassium channels that were attempted.  Approximately 1 out of every 4 G-protein 
coupled receptors was produced in bacteria.  The method of using a fusion protein 
appeared to yield the highest propensity for success.  Lastly, two out of the three MSL 
proteins expressed in E. coli.  In this particular case, the presence of the endogenous 
signal sequence affected production. 
 
 The desire to express eukaryotic membrane proteins in bacteria requires a 
comprehensive approach.  All three efforts necessitated the screening of every variable in 
order to either achieve or maximize expression.  In these experiences, the change in strain 
and growth medium had the largest impact on expression. 
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Appendix A:  Expression Optimization 
 
Step 1—Expression Plasmid Variation 
 
There exist a number of commercially available vectors designed to help the expression 
of proteins.  The traditional method of purification tag placement is an effective strategy. 
 
pET28b(+) N- and C-terminal His tag 
pET19b(+) N-terminal His tag 
pET21b(+) C-terminal His tag 
 
Producing proteins using fusion constructs has also proved to be an oftentimes successful 
means of expression. 
 
pMal-p2E 
 
Lastly, if the integral membrane protein of interest has an extracellular or periplasmic N-
terminus, the addition of E. coli signal sequences to promote secretion can be useful. 
 
pET26b(+) pelB leader sequence 
 
Step 2—Screening of Expression Strains and Temperature 
 
Many strains of Escherichia coli have been developed to facilitate the expression of 
difficult proteins.  These include BL21 RIPL (DE3), BL21 Gold (DE3), C41 (DE3), C43 
(DE3), RosettaBlue (DE3).  Temperature is also varied. It has been reported that E. coli 
grown at lower temperatures such as 25°C result in a different lipid composition that is 
more similar to eukaryotic membranes. 
 
Step 3—Screening of Growth Media 
 
Development of a media screen has proved to be useful for expression or optimizing the 
expression of certain membrane proteins.   
 
Media Tryptone Yeast 
Extract 
Beef 
Extract 
Malt 
Extract 
Glycerol 10X 
Phosphate 
Buffer 
GM1 32 g 20 g   16 mL 100 mL 
GM2 12 g 12 g 12 g  16 mL 100 mL 
GM3 12 g  24 g  16 mL 100 mL 
GM4 12 g 8 g 8 g 8 g 16 mL 100 mL 
GM5 12 g 12 g  12 g 16 mL 100 mL 
GM6 12 g   24 g 16 mL 100 mL 
GM7 12 g  12 g 12 g 16 mL 100 mL 
* Total volume is 1 L 
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Appendix B:  SeMet Growth Media 
 
The following protocol is designed for 1 L 
 
1)  The SeMet Growth Media is composed of 7 components: 
A: Salt Solution 
B: 1M CaCl2 
C: 1M MgSO4 
D: 50 mg/mL Kanamycin sulfate 
E: 20% Glucose 
F: 10X Amino Acids 
G: Selenomethionine 
 
2) The salt solution is composed of the following salts brought up with dH2O to a final 
volume of 850 mL, and autoclaved. 
Na2HPO4  6 g 
KH2PO4  3 g 
NH4Cl   1 g 
NaCl   0.5 g 
 
3) Make 50 mL stock solutions of 1M CaCl2, 1M MgSO4, and 50 mg/mL Kanamycin 
sulfate.  Sterile filter these solutions.  Make 1L of 20% (w/v) glucose and autoclave. 
 
4) Make a 1 L 10X amino acid solution (without methionine).  If using L amino acids, 
weigh out 400 mg per 1 L.  If using DL amino acids, weigh out 800 mg per 1 L.  
Autoclave. 
  
1. Glycine 8. Tryptophan 14. Cysteine 
2. Alanine 9. Serine 15. Lysine 
3. Valine 10. Threonine 16. Arginine 
4. Leucine 11. Asparagine 17. Histidine 
5. Isoleucine 12. Glutamine 18. Aspartic Acid 
6. Proline 13. Tyrosine 19. Glutamic Acid 
7. Phenylalanine   
 
5) After all solutions have cooled to room temperature, add components A–G together. 
 
A Salt Solution 850 mL 
B 1M CaCl2 540 uL 
C 1M MgSO4 2 mL 
D 50 mg/mL Kanamycin sulfate 1 mL 
E 20% Glucose 50 mL 
F 10X Amino Acids 100 mL 
G Selenomethionine 50 mg 
 
6) Inoculate with B834(DE3) cell containing plasmid expressing the gene of interest. 
